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Trial of BeG Vaccines in Sonth India 
for Tuberculosis Prevention 
Tuberculosis Prevention Trial, Ma as* 
The prot.ective effect of nCG vaccination in man has been evaluated in a number of 
controlled trials. In these trials, the protection observed varied from none to 80 per cent. 
In view of these conflicting results, a large scale nCG trial was planned in India and the 
protective effect of BCG vaccinatiou evaluated in a controlled, double-blind, community 
trial near Madras in south India in a population of about 360,000 persons, In this trial, 
all individuals aged 1 yr and above were tested with 3 IU of PPD-S and 10 units of PPD-B, 
and simultaneously, BCG vaccines and placebo were allocated randomly to all tho 'e aged 
1 mo and above. All individuals aged 10 yr and above were X-rayed, and from such persons 
whose photoftuorograllls were interpreted as abnormal two specimens of sputum were col­
lected and bacteriologically examined. Intenshe efforts were made, by mea us of regular 
follow-up ~urveys every 21 yr and more frequently, by selt.'Ctive case-tinding among sus­
peds and further by maintaining permauent diagnostic services for symptomatics, to 
identify all new cases of tuberculosis occurring in the community. MutuaJlyexclusive 
random samples of the population were retested with tuberculin at 2§ 100, 2; and 4 yr after 
the intake in order to evaluate the tuberculin seusitivity over time in the study population. 
TIle study population was charaderised by a high premlence of tubCl"culous iufection nd 
disease as also by a vcry high prevalence of uonspecific sensitivity. This report presents 
findings of tJle first 7! yr of follow-up. The, tubereuliu seusithity induced by BeG vacci­
nation was highly satisfactory at 2! mo but waned considerably between 2t mo and 21 yr 
with no further waning in sensitivity thereafter. IncidenCE' of infection was high in the study 
population. However, incidence of bacillary disease was more frelluent among iuitial 
tuberculin reactors, especially amllng the older persons, thau among uon-reactors of whom 
the majority were in the younger age groups. 1 he distribution of ncw \:ases of pulmonary 
tuberculosis among those not infeeted at intake did not show any evidence of a proteclh'e 
effect of BCG. Certain hypotheses ttat may explain the findings have heen discussed. 
*The Tuberculosis Prevention Trial, Madras, is a project under the auspices of the Indian Council 
of Medical Research, New Delhi in collaboration with the World Health Organisation, and (until June 
1976) the Centre for Disease Control, US Public Health Scrvice, USA. This report was prepared by 
Dr G. V. J. Baily, Projecl Director, Dr Raj Narain, formerly Project Director, Dr S. Mayurnath, 
Assbtant Project Director, Shri R. S, Vallishayee, Senior Statistidan and Dr J. Guld, Consultant, 
World Health Organisation. Baderiologieal investigations were carried ont during intake at the Union 
Mission Tuberculosis Sanatorium (Director at that time : Dr J. Primodt-M</>llcr), Madanapallc, 
and later at the Tuberculosis Research Centre (Director: Dr S. P. Tripathy), Madras 
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WHILE the prote..:tive effect of BCG vaccinc against tuberculosis can 
be demonstrated experimentally 
through vaccination of suitable animals 
and subsequent challenge with Mycobac­
terium tuhermlosis. evidence of the pro­
tective effect in man is best obtained by 
means of controlled clinical trials. A 
controlled clinical trial should as far as 
po~sible be, double blind, and the allo­
cation of treatments random. 
A number of sUl:h controlled BCG 
trials have been carried out in recent de­
cades with very conflicting rcsults. A trial 
in a population of American Indians l in 
the late 1930's indicated a high protcl:tion 
(of the order of 80 per cent) and so did a 
trial among British school-leavers 2'3 start­
ed in 1950. In thcse trials the populations 
were followed for twenty and fifteen years 
respectively. Of the four trials in the 
United Statcs, startcd betwcen 1947 and 
1950, the one carried out in Puerto Rico~ 
indicated a modest protective effect esti­
mated at 31 per eent while two trials in 
Alabama and Georgia"'" and one in 
IIIinois7 failed to show any protection. 
Also started around 1950, a trial in south 
India8,g indicated moderate protection. 
For a detailed review and discussion of 
these trials the reader is referred to 
Sutherland lo• 
An explanation offered at an early 
daten for these contradictory results was 
that sensitisation by mycobacteria other 
than M. wherculosis causing nonspecific 
sensitivity to tubcrculin, might interact 
with, and possibly mask, the protective 
effect of BCG vaccination. But it has 
also been suggested that the potency of 
the vaccines used may have varied 12 
either in terms of simply tbe dose, or 
more likely in terms of differing antigenic 
value of the strains of BCG used. 
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Vaccines for thc different trials were 
prepared in different laboratories from 
cultures that had been propagated for 
many years and had therefore been suh­
ject to mutation and selection of mutants 
(in fact, the original RCG strain is not, 
strictly speaking, a '~train' according to 
present standards, since it was not derived 
from a single colony hut from a \\'ho]e 
cultur(13). Uifferences in immunogeni­
city and virulence among the strains used 
in some of the trials (;ould be demons­
trated in cxperimental animal models 
and the potency differenl:cs observed in 
these models were closely associated with 
the observed differences in protection1 H 7. 
Thus, the strain could indeed be an impor­
tant variable. This is also suggested by 
the fact that, for the trials conducted in 
Georgia, Alabama and Illinois in which 
BCG vaccination appeared ineffective5- 7, 
the vaccine had been prepared by the 
same laboratory. On the other hand, 
vaccine from this laboratory proved highly 
effective in another trial among Chicago 
infantsls. In another trial, among British 
school-leavers3, two very different vacci­
nations with BCG and vole bacillus 
vaccines (the former administered by 
injection, the latter by multiple puncture) 
appeared to give the same level of pro­
tection. The actual relevance of the 
vaccine strain viS-(/-l'is the protective 
effect in man therefore remains proble­
matic. 
Very little is known about the corre­
lation of dose of BCG and protection 
against tuberculosis in man. On the 
other hand, the dose-response function 
for delayed hypersensitivity in man is 
well known: roughly speaking, a ten-fold 
decrease of the dose may be expcl:tcd to 
yield, in post-vaccination tuberculin test­
ing, reactions some 2-5 mm smaller in 
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diameter1!1·20. Jn complete contrast, the 
dose-response function in the guineapig 
is zero over a wide range (i.e., from the 
standard dose down to 10-5 of that dose), 
if only sufficient lime is allowed after 
vaccination. This has becn documented 
with great precision for delayed hyper­
scnsitivity2U but also seems to be true for 
protection 21 • A retrospective analysis of 
the British trial indicated that the vari­
ation in the protective effect for batch-to­
batch variations in viable Llllils over a 
range of4: I was too small to be statistically 
liignilicant22• However, vaccines from 
different la boratories vary more than tbat 
and vaccinations are ortcn carried out with 
vaccines that are severely damaged in 
terms of reduction in viable counts at lhe 
time or vaccinations either due to poor 
storage or faully handling. 
It is now generally accepted that low­
grade tuhereulin sensitivity is nonspecific, 
i.e., due to sensitization by mycobacteria 
not identical with M.wberculosis, yet 
antigcnically related 23-27. Such nonspeci­
fiC tuberculin sensitivity is highly prevalent 
in most tropical areas and exists also in 
some subtropical arcas 2H• Studies of 
delayed hypersensitivity to mycohacterins 
prepared from various mycobacteria indi­
cate that the causalive organism(s) may 
be antigenically close to M. allium and to 
Runyon's groups U and 11[29-32. It has 
heen suggested that such sensitization 
could be associated wilh protection 
against tuhen:ulosis and possibly mask 
the protective effect of BCG vaccination. 
That hypothesis was confirmed in experi­
ments in mice;J'~ and in guilleapigsll . This 
was also bornc out in a surveillance pro­
gramme of naval personne13~ and in a 
retrospective study of a rural population 
in south India35• In thcir extensivc series 
of experiments, in guineapigs, Palmer 
and Longll were able to demonstrate a 
protective cJfect of M. Gl'illll1, of 
M. kansasii, and of a scotochromogcn, 
inferior to the protective effect of BCG but 
still quite significant. In order to simulate 
the vaccination wilh BCG of persons 
having nonspecific sensitivity, they super­
imposed BeG vaccination on infection 
with M. avium or 'atypical' mycobacteria 
and found, comparing with animals vacci­
nated with BCG alone, that the protcctive 
effects were not additive: ''Cutaneous 
luhcreulin sensitivity and anti-tuhereulosis 
effects which follow BCG vaccinalion are 
the same regardless of whelhcr or not a 
previous mycobacterial infection had al­
ready produced some tuberculin sensi­
livity and anti-tuberculous eO'ects". The 
authors offered this phenomenon as an 
explanation for the contradictory results 
of the American trials from 1947 and the 
British trial, pointing out thal the tri.als 
with low or no protcction were carried 
out in populations "saturated early in 
life wilh infections with atypical myco­
bacteria". In thosc trials in which BeG 
vaccination proved ineffective, or had a 
low effectiveness, the presence of non­
specific sensitivity was indeed demons­
trated, hut detailed quantitative analyses 
showed that nonspecific sensitivity alone 
could not have masked completely the 
cOcet of a vaccine that would have had a 
high efficacy in a nonsensitiscd popula­
ti.on12'36. Also, in the trial in Puerto 
Rico in which a modest proteclion was 
observed, this applied equally lo thc 
population with and without low-grade 
sensitivity~7. In India, nonspecitic sensi­
tivity is highly prevalent except in a few 
areas situated at higher altitudes'J8-to. 
Thus while knowledge of the protective 
effect of BCG would be desirable among 
both kinds of populations, i.e., with a 
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high prevalence of nonspecific sensitivity 
and withollt, the former would be far more 
relevant in India, as in most other tropical 
countries. 
Finally, it should be menti.oned that 
one factor, the presence or absence of 
tuberculous infection in the trial subjects 
was in fact considered in relation to selec­
tion of subjects in all the trials. However, 
in view of the very rationale for vaccina­
tion against tuberculosis, this factor was 
implicitly assumed to play such an impor­
tant role that no attempts were made to 
investigate it further; infected subjects 
have invariably been excluded from vacci­
nation trials. The WHO Expert Committee 
on Tuberculosis, in its 8th report41 , recom­
mended the omission of tuberculin test 
for screening before vaccination" .... in 
countries where BCG vaccination is 
essential to the effective control of tuber­
culosis, where cost is of major importance, 
and where prior tuberculin test would 
considerably reduce the coverage". Such 
direct vaccination is being practiced ex­
tensively in many developing countries 
including India. Judging from the size 
of accelerated vaccination lesion, it 
appears that a vaccine dose of BCG is 
equivalent to a few units of tuberculin 
only. A number of studies in recent 
years have shown tbat vaccination of 
persons infected with M. tuberculosis 
results in vaccination scars that are slightly 
larger than in uninfeeted persons. .N0 
other significant effects have been demons­
trated. Such studies have been reviewed 
by Ten Damu and Egsmose43• An 
entirely different possibility is that nCG 
might increase thc specific immunity in 
people infected so many years ago that 
their naturally acquired immunity (from 
the original, virulent infection) might have 
waned. A sufficiently large study inclu­
ding elderly people with a high incidence 
of tuberculosis would illuminate this 
question. 
Neither the empirical findings of the 
field trials nor other epidemiological 
observations gave any indication of further 
relevant factors, but lack of detailed 
epidemiological knowledge could well 
have been important in this respect. The 
apparently conflicting trial results, as wen 
as the fact that the vaccines employed 
in the trials cannot be reproduced, called 
for further and more systematic research. 
To some extent, this had become easier 
because of the technical progress made 
meanwhlle in the preparation of BCG 
vaccine. Freeze-drying techniques deve­
loped made it possible to prepare a stable 
product from any BeG strain, and to 
maintain the strains as seed lots without 
the risk of further genotypic alterations44 • 
Accordingly there was a need to undertake 
further field trials with vaccines prepared 
from different seed lots and in different 
dosages, and to conduct these trials in 
populations where nonspecific tuberculln 
sensitivity was present and in others where 
it was absent; the incidence of tuberculosis 
in the study population should be fairly 
high, and BCG vaccination should not be 
a current public health measure. A trial 
satisfying most of these conditions was 
organised in south India by the Indlan 
Council of Medical Research (ICMR), 
New Delhi, in cooperation with the World 
Health Organisation and the Center for 
Disease Control, US Public Health Ser­
vice, in a population where nonspecific 
tuberculin sensitivity was highly prevalent. 
Unfortunately, a contrasting area in which 
nonspecific tuberculin sensitivity was of 
low prevalence, or even absent, could not 
be identified in India. 
The objectives of the present trial were 
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to obtain : (I) a precise estimate of thc 
protective effect of BCG vaccination 
against tuberculosis in the non-infected, 
(2) the effect of BCG vaccination in 
persons already infectcd,(3) the protective 
effect of different strains of BCG, (4) the 
influence of dosage of BCG on the pro­
tective effect and (5) epidemiological data 
on tuberculosis in the community. 
2. History of the BeG trial 
In 1963, the Government of India took 
up the question of conducting a BCG 
trial in India. There was still some con­
troversy in the country about the usc of 
BCG, and it was felt that the problem had 
to be settled by a controlled field study 
undcr Indian conditions. The WHO 
sccretariat was consulted and it was agreed 
that such a trial involving a large popu­
lation and followed over a number of 
years would require substantial resources 
and thus need funding from spcdal 
sources. The project was initially financed 
largely from the United States PL 480 
funds, supplemented by a WHO research 
grant. Later the WHO grant was supple­
mented by grants from the Danish 
government. When the PL 480 grants 
ceased in 1976, the main funding of the 
project was done from research grants 
from the Department of Science and 
Technology, Government of India. As 
from 1979 the main funding of the pro­
ject is being done by the Indian Council 
of Medical Research. Administratively, 
the project was originally a section of the 
National Tuberculosis Institute, Banga­
lore, and from 1966, a separate project 
under the Indian Council of Medical 
Research. 
A research protocol for a controlled 
field trial (with placebo and with 2 doses 
and 2 strains of BCG) was accepted by the 
Indian Council of Medical Research in 
1968. As it was envisaged that the pro­
ject would function as a section of the 
National Tuberculosis Institute it was 
decided, for operational convenience, to 
conduct the study in an area in south 
India, not far from the Institute. Most of 
south India has been repeatedly covered 
with BCG, with a coverage which, while 
rarely above 30 per cent among the 
younger age-groups, was still high enough 
to interfere seriously with a controlled 
trial. Two areas, however, had been 
kept free of BCG vaccination programme 
over the years: part of Bangalore District 
in Karnataka State, and all of Chinglcput 
District (near Madras city) in Tamil Nadu 
State. 
With access to data already collected 
in Bangalore District, by the National 
Tuberculosis Institute45'46, and after the 
project had carried out sample surveys of 
its own in Chingleput District47 , it became 
clear that the prevalence of tuben:ulosis 
was 50 to 100 per cent higher in the latter 
place, which accordingly was selected for 
the trial. A contributory justification for 
selecting this area was its 'high prevalence 
of leprosy: the hope at that time 
was to examine simultaneously the 
possible preventive effect of BCG against 
leprosy, already the subject of studies 
SO
•elsewhere with conflicting rcsults4S­
The sample surveys in Chinglcput 
District were carried outin Kanchipuram 
Taluk, located in the southern part, and 
Ponneri Taluk. located in the northern 
part of the District, each survey covering 
villages totalling 10,000 to 12,000 persons. 
The prevalence of bacillary tuberculosis 
in persons 10 yr and more was estimated 
at 9 per 1000 in Ponneri and 7.5 per 1000 
in Kanchipuram and it was therefore 
decided to include part ofPonneri Taluk, 
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the whole ofTrivellorc Taluk (comprising 
Kadambathur, Trivellore, Poondi and 
Ellapuram panehayat unions), and part 
of Tiruttani Taluk (Tiruvalangadu pan­
chayat union). However, during intake 
it turned out that the cooperation of the 
population in Ponneri Taluk was vastly 
inferior and eventually Ponneri was aban­
doned for the trial. 
3. Study design 
Factorial design --- The experimental 
design used in the study may be described 
as a "factorial design" which is an integral 
clement in the now c1assiealexperimental 
methodology developed by Fisher''>l and 
others. In such a design, two or more 
faclors arc varied simultaneously, usually 
in such a way thateach level of each factor 
is tested equally often for any combination 
of levels of the other factors, If the effect 
of one factor depends on the level of 
another factor, this design will ensure 
against false generalisations which might 
have been made from an emperical esti­
mate obtained under one particular set 
of conditions, It is desirable for an optimal 
factorial design that it should be'balanced', 
i.c., contain all possible combinations of 
the various factors under investigation. 
The design can be considered to be a 
factorial design, the factors being the 
vaccine strain (and placebo) and the 
vaccine dosage, Thcse factors were com­
bined in a single experiment by allocating 
one of the following treatments, randomly 
to any individual. 
(a) Strain 1331, 0.1 mg; (b) Strain 
1331, 0.01 mg; (c) Strain 1173 P2, 
0.1 mg; (d) Strain 1173 P2, 0,01 mg; 
(e) Placebo. 
It will be observed that the lise of four 
equal subgroups (a), (b), (c) and (d) 
above is superior to a design (with the 
same total population) wilh, say. only the 
first three suhgronps. With four equal 
sub-groups, the strain dlect would be 
(a; h) -- (c -i- d) and the dose effect 
(a + c) - (b --:- d)*. With only three 
subgroups the strain eITed would he 
(a--c) and the dose cffect (a - h). In 
the former design, every persoll contri­
butes to either estimate, in the latter only 
two-thirds contribute to either estimate. 
It is also an advanlagc to have a 
common control group for all the vacci­
nated groups ohtaining an average pro­
tectionof(e)-k(a+b ;c-;-d), wherek 
is a factor adjusting for group size. 
Otherwise to carry out two trials e.g., 
one with (a) above versuS a control group 
(e) and the other (a), (h), (c), (d) above 
hut without controls would be a distinctly 
inferior design both in economic and in 
logical terms. 
Allocation of 1'''C(';I1('.\' -- It was decided 
to make the allocation completely random 
i.e., without any attempt at balanced or 
stratifted allocation or by cluster. With 
a study of this size (see, Size of population) 
the proportion of persons tbus allotted 
to different vaccines within each stratum 
will differ very little and not only the 
allotment itself but also the later analysis 
is greatly simplified. In the analysis of the 
follow-up it is pcrmissihle to disregard 
the 'sampling error' in allocating different 
vaccines. The results seen as morhidity 
(or mortality), even when cumulative 
over the years, would rarely exceed one in 
a hundred; thus the sampling error would 
be very much larger for the numerator 
(number of cases) than for the hundred 
times larger denominator (numher 
vaccinated) and it can be shown that 
*The last 'jruJependent contrast', (a-b~+d). 
is interaction or strain and dose 
7 TUDERCULOSIS PREVENTION TRIAL, MADRAS 
under these circumstances the variance 
of the rate will increase by only one per 
cent if the number vaccinated is not 
counted but deduced from the a priori 
probability of being vaccinated. One 
minor deviation was made from the 
cumplete individual randomisation, in 
that the two BCG strains were allocated 
randomly to clusters each consisting of 
persons vaccinated from one set of three 
ampoules: two ampoules with 0.1 and 
0.01 mg of the same strain and one place­
bo ampoule. In reducing the nnmber of 
ampoules used simultaneously to three 
rather than six, the strain factor was 
chosen for confounding with clusters. 
F or the entire study since the num bcr of 
such clusters was expected to be large 
(about 1000 clusters for each strain) it 
was presumed that this factor would also 
be wcll randomized. 
Size of population - In the earlier 
trial in India by Frimodt-Mr/>ller and 
associates8, the protection is quoted as 
60 per cent, with a confIdence interval 
(at the 95 per cent level) of 14 to 84 
per cent. Thc con fIdence interval varies, 
roughly speaking, with thc square root 
of the number of cases. There were 30 
new (incidence) cases, in this earlier trial, 
arising among 11,000 initially non-infected 
pcrsons. But even with 1000 cases 
similarly distributcd in a new trial, i.e., 
715 cases among a non-vaccinated half 
of thc population and 285 among the 
vaccinated, the confidence interval (at 
the 95 per cent level) would still be from 
54 to 65 per cent. It follows that the trial 
should be as big as financial resources, 
qualified manpower and operational con­
ditions permi 1. It was expected that out of 
all new cases a sizeable fraction would 
belong to those tuberculin negative at 
the time of vaccination. In the longitu­
dinal survey of the National Tubercu­
losis Institute, BangalorcS2, during the 
first 1t yr of obscrvation 19 (28 pCI' cent) 
cases out of a total uf 67 incidence cases 
originated from the tuberculin negatives. 
It was thus expected that in a study popu­
lation of 250,000 persons with an annual 
incidence of 2 cases per 1000, already the 
first 2t yr should yield 1250 cases out 
ofwhieh 350 would bc previously negative 
and thus contribute to the main purpose 
of the trial, yielding a igniflcant if 
not a very precise estimate. 
4. Choice of BCG strains, vaccine 
dosages and placebo 
Of the several strains of BCG that 
exist and are being us d for vaccination, 
only strains fulfilling the requirements 
formulated by the WHO Expert Committee 
on Biological StandardizationH were con­
sidcred. The most fundamental of these 
requirements is that a strain must exist 
as a well-defmed and well-examined 
'primary seed lot', so that the vaccine 
used in the trial can be reproduced at any 
future time. Preferably, the residual 
virulence in man should be well-known 
from previous wide use in vaccination 
programmes. A number of such strains 
exist and are kuown from studies in recent 
years to difTcr among themselves in many 
respects, as mentioned in the Introduction. 
The question was whether to select only 
one strain or ",:hether to include several 
with widely differing properties. The 
most tempting was no doubt strain 172 
(the 'Tokyo' strain), which has an excep­
tional resistance to freeze-drying (T. 
Hashimoto, personal communication), and 
to adverse storage conditionsS3 , but 
which combines a high allergenic potency 
in man54. with a comparatively low activity 
in ccrtain experimental animal studies"s-s7. 
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But while the indusion or widely different 
strains would have been of scientific i 11­
terest, it would have implied a correspond­
ing increase in the study population. III 
a final compromise, two strains were 
selected that are quite alike in terms of 
in vivo activity though their in vitro pro­
perties difTer to some extent. In the 
unlikely event that one of the two strains 
turn out to be better than the other, this 
in itself would be a result or great practical 
importance. The strains selected were 
'strain 1331' and 'strain 1173 P2' rererred 
to commonly as the 'Copenhagen' and 
the 'Paris' strains respectively. 
Strain 1331 - There wcre two parti­
cular reasons ror including this strain: 
it has been lIsed in India since 1966 for 
all rOlltine production or BCG vaccine 
and it is derivcd from a strain which was 
used in the successful British trial in 
1950-52. The history of this strain is as 
follows: 
In November 1931, the Statens Serum­
institut in Copenhagen received a new 
BCG culture, labelled 423, from Imtitut 
Pastcur, Paris, and abandoned the one 
used previously as being too virulent. 
Ovcr the following years, apart rrom the 
cultures kept for seed in the routine 
production, several other lines were pro­
pagated for varying periods or time on 
either liquid Sauton medium or on bile­
potato. (Here and in the following, the 
word 'line' is used for a separate series of 
sub-cultures not suspected of being gene­
tically different from the mother strain). 
In 1949, a liue that during the previous 
five years had been kept exclusively 
on bile-potato was transferred to Sauton 
via one passage on Santon-potato, and 
kept on liquid Sauton ever since by trans­
fer every tenth to eleventh day. Three 
parallel lines wcre kept with staggered 
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intervals so as to allow production on 
one particular weekday every week. The 
liquid vaccine supplied for the British 
trial must have consisted of virtually equal 
parts of these three lines. During the 
period 1950-1958 nearly all cultural 
transrcrs were made by the latc Dr 
K. Tolderlund, who aimed at keeping the 
growth characteristics of the strain cons­
tant by always selecting 'typical' parts of 
the previous culture for seeding the next; 
no change was observcd in the morpho­
logy of the strain during these years 
(K. Bunch-Christensen, personal commu­
nication). In October 1958, an ampoule 
of liquid vaccine from Copenhagen 
(routine batch number 1331) was trans­
ferred, in the Japan BCG laboratory, 
Tokyo, to glycerol bile-potato and was 
kcpt on this medium with a total of 
45 serial transfers, until September 1960 
when it was transrerred via onc passage 
on Sauton-potato back to Sauton, the 
second passage of which was freeze-dried 
with I per cent sodium glutamate, as one 
batch comprising 5 drying lots (T. 
Sawada, personal communication). The 
batch was later transferred to Copenhagen 
and was examined extensively both as 
vaccinc and as secd matcrial. Thc viabi­
lity was found to be rather low, indicating 
a survival arter freeze-drying of approxi­
mately 5 per cent. But as a seed it was 
found to be very suitable, yielding vaccines 
that were indistinguishable rrom those 
produced from the lines maintained 
traditionally hy serial sub-cultures on 
Sau ton (K. Bunch-Christensen, personal 
communication). The batch was adopted 
in 1966 as the 'Copenhagen' seed lot. It 
is stored in deep-frecze, and tests ovcr 
the years have indicated 110 significant 
loss or viability. 
Strain 1173 P2 - This strain is distri­
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buted from the Institut Pasteur, Paris, 
and is currently used in more than 20 
BCG production laboratories in al! parts 
of the world. It was derived ill 1961 
from a single colony that (out of 30 
colonies examined) yielded cultures that 
(especially in terms of pigmentation) 
"had properties most closely representative 
of the usual BCG, that is, the Paris BCG 
strain" (1. Augier, F. osloff, personal 
communication). This strain, 1173 P, 
was lyophilized and the second batch, 
1173 P2, is now the primary seed lot of the 
'Paris' strain. Only a small number of 
ampoules are left of this batch, so that 
for all ordinary production purposes 
secondary seed lots are used, three passa­
ges removed from the primary lot. 
The strain shows a high and consistent 
activity in several animal models and a 
hio-h allergenic potency in man, as de­
mo tratcd in the studies already quoted. 
Dosage-Nominal dosages of vaccines, 
from reputed laboratories, have varied 
in r c nt years between 0.2 and 0.015 mg 
(semi-dry weight), and deterioration under 
held conditions further widen the range. 
As mentioned earlier, a previous study22 
failed to show any difference in protec­
tion for an inadvertant variation in 
strength ofvaccine of4 : 1. It was d.:cided 
for the present study to use doses of 
0.1 and 0.0 I mg, the former dosc con­
sidered to be the strongest that could be 
used in young children without an undue 
complication rate, the latter a compromise 
that (judging froIll BeG induced tuber­
culin sensitivity) might still bc expected 
to add measurable protection in persons 
with naturally acquired low-grade sensiti­
vity. 
Placebo - A double-blind technique, 
with placebo 'vaccination' of the control 
group, was considered essential to ensure 
identical treatment of the vaccinated and 
the controls. 0 serious attempt was 
made at flIlding a placebo that would 
result in a skin lesion simulating a BCG 
lesion. It was felt that to fmd a substance 
that would cause the same kind of scar 
yet be biologically innocuous would have 
been difficult. An innocuous substance 
(Dextran 500, Pharmaeia, batch To 
852, 0.625 mg per 10 ml ampoule) was 
therefore used, freeze-dried to form a 
powder of the same appearance as frecl.e­
dried vaccine. 
5.	 Preparation and testing of BeG 
vaccines 
Vaccine preparation - The vaccines 
llsed in the trial were prepared as follows. 
An ampoule of the seed lot was reconsti­
tuted with 1-2 ml of Sauton medium and 
seeded on Sauton-potato. After 3 to 4 wk 
a loop of the pellicle was transfcrred to 
liqui I Sauton medium from where, after 
10 days, trans~ r was made to a second 
Sauton medium from which the harvest 
for vaccine production was collected after 
6 days (for 1173 P2) or 7-8 days (for 1331). 
The microscopic morphology, the pH, 
and the sterility of the culture were exa­
mined for each flask and l1asks with abnor­
mal fl\1dings discarded. 
Liquid surplus was removed in a 
Birkhaug apparatus, pooling harvests 
from 3 or 4 flasks, and a suitable amount of 
the moist bacterial mass \vas transferred 
to a ball-mill for homogenisation and 
dilution with distilled water with sodium 
glutamate, 4 per cent, to predetermincd 
concentrations in terms of moist weight. 
These suspensions were then dispensed 
in ampoules, frozen immediately after­
wards, and kept in deep-freeze till the day 
of freeze-drying. Several lots might thus 
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be prepared from one batch, each lot 
dried on a different day, but all originating 
from a single sllspension. Freeze-drying 
was performed owr 20 h and the am­
poules hand-sealed under vacuum imme­
diately after drying. In Copenhagen, 
suspensions of 20 and 2 mg per ml were 
dispensed with 0.5 rnl per 10 ml ampoule, 
resulting in ampoule contents of 10 and 
1 mg respectively. In Madras, 5 ml 
ampoules were used throughout, contain­
ing 5 and 0.5 mg respectively. 
The vaccines were released for use only 
after satisfactory completion of all routine 
tests in the production laboratories, i.e., 
tests for viability, for safety and for non­
contamination. 
Vaccine lots Vaccines and placebo 
were supplied 6 times to the trial thrice 
from Copenhagen and Madras each. 
Each supply comprised one batch of 1331 
and one of 1173 P2, eaeh in one or two 
drying lots for each of the two dosages. 
For preparation of vaccine from 1331, 
the primary seed lot was used in all cases. 
For 1173 P2, a special seed lot, 1173 P2S 
dated April 1968, was prepared in Copen­
hagen from the French sced lot 1173 P2 
lot 5. 1173 P2 lot 5 is 6 passages removed 
from P2. The first of the six batches 
from strain 1173 P2 used for vaccination 
in the trial was P2S itself (though a sepa­
rate drying lot) ; the other five were 
prepared with P2S as seed lot, three 
passages removed. Thus the 1173 P2 
vaccines used in the trial were 9-12 
passages removed from P2. 
Gfthe primary seed lot 1331, close to 
2000 ampoules, of 1173 P2, 80 ampoules, 
of 1173 P5, 300 ampoules and of 1173 
P2S, 2000 ampoules are still available. 
Randomization and labelling of am­
poules - The four vaccines and the 
placebo ampoules were packed by the 
production laboratories in cardboard 
boxes of three ampoules each. Boxes 
were numbered A OOl-A 999, B 001­
B 999, etc., and for each box number the 
strain (either 13310r 1173 P2) was selected 
at random by means of a table of random 
digits (there was thus no stratifIcation and 
therefore no equalization of the total 
number of boxes of one and the other 
strain). Each box contained an ampoule 
with 0.1 mg BCG per 0.1 ml (after reconsti­
tution), an ampoule with 0.01 mg per 
0.1 ml (of the same strain) and a placebo 
ampoule. A random permutation of the 
digits 1, 2 and 3 was allotted to eaeh box, 
for random coding of the three ampoules. 
From the randomized scheme thus ob­
tained (see Table 1), sheets of labels were 
typed, each sheet for one kind of vaccine 
only, and the labels were (after the sheets 
TABLE I - SPECIMEN COpy O~ RANDOM1SED 
SCHEME FOR ALLOCATION OF AMPOULloS TO BOXES 
Box Strain Ampoule nil bcr 
No. 
0.1 mg 0.01 mg Placebo 
A-SOl Danish I 3 2 
A-502 French 2 3 I 
A-503 French 2 3 I 
A-504 French 2 3 I 
A-505 Danish 2 1 :J 
A-50G French 3 I 2 
A-507 Danish 2 ( 3 
A-50S French 3 2 I 
A-509 Dunish 2 1 3 
A-510 French 3 2 I 
A-511 French 3 2 1 
A-512 Danish 2 3 1 
A-513 French 2 3 t 
A-514 French t 3 2 
A-5IS Danish 1 3 2 
A-516 French 3 2 I 
A-517 Danish 2 3 1 
A-SIS Danish I 2 3 
A-519 Danish 2 3 1 
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ad been photocopicd, sec Fig. 1) applied 
to one lot of vaccine at a time. Afler all 
the lots of a particular supply had been 
labelled, they were packed as described 
above, three in eacll box, at which occasion 
errors such as usc or the same code 
number for two ampoules would be re­
vealed. 
Custody of codes The complete set 
,of codes (illustrated in Table 1) is kept 
by the production laboratories. The 
project's statistical stalT recei ved during 
the earliest stage of the follow-up, copies 
of the codes for samples of population 
in whom the immediate elTect of vacci­
nation was assessed (see next para), but 
these copies werc destroycd in each case 
as soon as the analysis of the assessment 
was completed. Later, the codes as they 
appeared on the photocopies of labels 
(Fig. 1) were punched and transferred 
to tape outside India and copies of this 
tape storcd in Geneva (WHO) and 
New Delhi (ICMR). All further decoding 
of the vacci nation status of cases (and 
other strata of the population) is done 
by transmitting the recorded vaccine 
ampoule code numbers for all diagnosed 
cases to New Delhi from where the desired 
statistical tabulations are returned to the 
project. Thus the vaccination status of 
the individual patient will remain unknown 
to the project staff. 
Assessment of vaccination lesions in 
man - As a running check on gross errors 
in thc allocation and registration of vacci­
nations, a 10 per cent cluster sample was 
randomly selected for examination of 
vaccination lesions 2~ months (av. 75 
,days, range 62-99 days) after vaccination. 
For selecting the 10 per cent sample, each 
panchayat, which is an administrative 
unit consisting of 2-3 villages, was divided 
into 10 clusters of households. House­
holds in one of these clusters, selccted at 
random, constituted the 10 per cent 
sample. All persons in the selected clus­
ters of households, except [or those regis­
tered after intake, wcre eligible for lesion 
reading. In each person the diameter of 
tissue destruction, i.e., pustula, opcn 
ulcer, scab or scar, was measured. The 
examination was performed wi thout 
reference to the pre-vaccination tuberculin 
status, and indeed without access to the 
coded vaccination record; thus the exa­
miner did not know whether any two 
persons had been vaccinated from the 
same ampoule. The coverage obtained 
were of the order of 80-90 per cent. 
For the vaccine ampoules used in the 
clusters thus assessed, the project obtained 
a decoding from the respective prot!uction 
laboratories, and the distribution of lesions 
by size was tabulated for each ampoule. 
The proportion of gross errors revealed 
by this procedure was extremely small, 
and thus the allocation procedurc could be 
deemed to be satisfactory. 
After n yr, an additional post­
vaccination examination was carried out 
in another cluster sample, of 5 per cent. 
The sampling methodology was as follows: 
firstly, one out of every 4 panehayats was 
selected at random and then in the selected 
panehayat two out of the ten blocks of 
households were randomly selected giving 
a 5 per cent random sample. If by chance 
one of the two blocks selectcd hat! already 
been selected earlier for the 2! month 
retesting, it was just passed over and the 
next block in the random order selected. 
All individuals in the households included 
in these blocks were eligible for retesting 
except children born after intake. The 
remaining clusters, 85 per cent, were 
included for examination after four years. 
For these two later examinations oflesions, 
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Fig. 1 - Specimen sheet of labels for ampoules 
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the distributions of scars by ampoule 
were tabulated by computer by the statis­
tical department of the Indian Council 
of Medical Research, New Delhi. 
In a random sample of BCG boxes, 
representing persons examined for lesions 
at each of the three examinations men­
tioned above, the distribution of scars 
(presence or absence) for each of the two 
vaccine doses and the placebo was seen. 
The proportion of lesions (scars) observed 
was 98.5 per cent for the 0.1 mg dose of 
vaccine, 85 per cent for the 0.01 mg dose 
of vaccine, and 10 per cent for persons 
given the placebo. 
Three statistical tests were constructed 
for picking out exceptionally unlikely 
distributions of lesions by ampoule. The 
deviation from a proportion of 98.5 per 
cent scars for the 0.1 mg dose of vaccine, 
85 per cent for the 0.0 I mg dose of vaccine 
and 10 per cent for the placebo, was 
assumed to vary from ampoule to ampoule 
according to the binomial distribution, 
and this assumpti.on was tested by means 
of the chi-square test; further, the distri­
bution by size of lesion (scar) was pre­
sumed not to have a larger mean for the 
ampoule with 0.01 mg dose of vaccine 
than for the ampoule with 0.1 mg dose 
of vaccine, from same box, and this was 
tested by means of a one-tailed HesL. 
The distributions of lesions for the three 
ampoules of each box were tested for dis­
agreement with each of these four hy­
potheses, both at a probability level of one 
in ten thousand and a probability level of 
one in a thousand. Out of a total of 
2744 boxes, nine boxes fell outside the 
one in ten thousand level of probability, 
and an additional 3 boxes outside the one 
in a thousand probability. The nine 
boxes are much beyond the expected value 
(one in ten thousand out of 2744, or 0.3 
box) while the additional 3 boxes between 
the one in thousand and the one in ten 
thollsand level, quite correspond to ex­
pectations. Correspondingly, 501 persons 
(out of 260,000) recorded as having been 
vaccinated from any of the nine boxes 
have been classified as 'vaccination un­
certain', while persons from the last 3 
boxes have been accepted for the main 
purpose of the trial. 
To what extent the nine errors origi­
nated in the production laboratories (e.g., 
wrong labelling) and to what ext~nt in 
the field (e.g., tilling a syringe frOID the 
wrong ampoule) is not dear from inspec­
tion of the actual distributions, but also 
Obviously of little interest considering the 
rarity of such errors. 
After excluding persons 'vaecinated' 
with vaccines or placebo from the nine 
boxes, it would still be of interest to study, 
for the rest of the boxes, the proportion 
of persons without a BeG scar, though 
vaccinated, and with a BCG scar, though 
given the placebo. The freq LlellCY of 
such (non-sampling) errors is shown in 
Table 2. Only persons betwcen 1 mo 
to 29 yr are considered, as those 30 yr 
and above were not eligihle for examina­
tion at 4 years. The magnitude of these 
errors was not much. However, for each 
of the three treatments, the frequency of 
errors at 2~ and 4 yr was significantly 
more than that at 2~ months (P<O.OI). 
Analysis of the data by age showed 
that the frequency of persons withont a 
scar, though vaccinated (with either 0.1 
or 0.01 mg dose) was the highest in the 
youngest age groups. This is not surpr­
ising and has been reported earlier; for 
instance Patel and Shawss reported that 
a number of new born vaccinated infants 
did not develop a scar; nor is it surprising 
that a significantly higher proportion of 
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TAl:ILF. 2 - PROPORTION OF PE!<SONS WITHOUT A 
BCG SCAR, THOUGH VACCIN.~TED, ANI} WfTH A 
BCG SCAR, THOUGH GIVEN TI-IE PLACERO AMONG 
THOSE AGED 1 MO TO 29 YR 
Interval from intake
 
Treatment given
 
2! 010 21; yr 4 yr 
0.1 mg of BCG 
No examined 6384 1758 23583 
No without a scar 14 32 250 
Percentage 0.2 1.8 1.1 
0.01 mg of BCG 
No examined 6330 1735 23630 
No without a scar 340 2115 2900 
Perceniage 5.4 12.6 12.3 
Placebo 
No examined 6650 1741 23833 
No with a scar 'j 83 118 1667 
Percentage 2.8 6.8 7.0 
persons given the 0.01 mg dose of BCG as 
compared to 0.1 mg dose did not develop 
a scar. But the greater rrcquency of 
vaccinated persons with no scar at 2t yr 
and 4 yr as compared to that at 2} 
months can only mean that the vaccina­
tion scar in a few persons did fade after 
the interval or 2t yr and was no longer, 
at least easily, discernible. The frequency 
of such persons at 4 yr was not higher than 
tbat at 2t yr suggtisting that the maxi­
mum fading took place within the first 
2! yr. 
On the other hand, the greater fre­
q uency of scars among those given placebo, 
at 2~ and 4 yr as compared to at 2t 
months has a different explanation. It is 
iikely that causes other than BCG vacci­
nation (i.c., small boils or injuries at the 
vaccination site) gave rise to scars and these 
were mistaken for BCG scars. If so, the­
frequency or such non-specific (i.e., non­
BCG) scars should not only be more after 
the longer intervals (as seen in Table 2) 
but also increase with age. Analysis of 
the data by age showed that this was 
indeed the case at 2~ and 4 yr but not 
so at 2~ months. Probably at 2t 
months the scar was still 'fresh' and well 
marked (and in some cases even showing 
a scab, pus or a crust) and not likely to be 
mistaken for a nonspecific scar. 
However, the important poiDt to stress 
is that the magnitude of these errors as 
reflected by the results of lesion reading 
at 2t 1110 was not much. In fact, 
these could be overestimates as they 
comprise not only errors or vaccination 
but also those or lesion reaJing. Thus, 
it can be safely concluded that after ex­
cluding persons 'vaccinated' from the nine 
boxes, as mentioned above, the results of 
lesion reading tallied well with the records 
of 'vaccination' and the allocation of 
'vaccines' to the population can be consi­
dered to be satisfactory. 
Post-vaccination allergy and local skin 
lesions soon after vaccination - Post­
vaccination tuberculin testing was carried 
out in the rust instance simultaneously 
with the reading or lesions (scars) 
2~ mo after vaccination. (Retesting arter 
longer intervals will be described in 
Chapter 15). Of the clusters selected 
for lesion reading a sub-sample or one­
firth (2 per cent or the total population) 
was selected (at random) for this testing. 
The coverage ror retesting was lower than 
for the lesion reading. [<'or persons below 
15 yr of age and with an initial tuberculin 
reaction or 0-7 mm the coverage was 56 
per cent for those vaccinated and 73 per 
cent for those given placebo (the retest 
may have been less acceptable for 
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those vaccinated because at that stage most 
of them still had a non-healed lesion after 
vaccination). 
While this sample is representative for 
the study population (being a random 
sample) and permits valid comparisons of 
the two strains uscd, the 6 supplies are not 
strictly comparable because each supply 
has been used at a difTercnt time and in 
au arbitrarily selected fraction of the study 
area. For the last (sixth) supply, few 
persons were vaccinated and very few 
retested. 
The retest dose was (as for the init.ial 
tuberculiu testing) 3 IU of PPO-S. The 
reactions (transverse diameter of indu­
ration) were read after 3 to 4 days, without 
reference to the previous tuberculin 
reaction or vaccination lesion. The 
results have been analysed separately for 
5-yr age-groups but 00 significant age 
trend was found. Post-vaccination tuber­
culin reactions, and local lesions, in 
children 1 month to 14 yr of age, tuber­
culin negative at intake (diameter of 
reaction 0-7 mm) are shown in Table 3, 
separately for each of the 12 batches. 
As expected, both tuberculin reactions 
and skin lesions are defmitely smaller for 
the 0.01 mg v3l:l:i.ne dose. Otherwise, 
there is no indication of significant bateh­
to-batch variation. 
A direct cumparison of two supplies, 
one from each laboratory - The second 
supply from Copenhagen and the first 
supply frolll Madras were used simul­
taneously in nearly the whole of Trivellore 
town (see Chapter 7), boxes from the 
two laboratories being allocated at 
random. (Trivellorc had been divided 
TABI.E 3 - MEAN SIZE OF TUDEBClJLTN REACTIONS (2 PER CENT RANDOM SAMPLE Of THE POPULATION 
EXCLUDlNG I> BLOCKS IN TRfVELLORE) AND LOCAL SUN LESIONS (10 PER CENT RANDOM SAMPLE), 
2t MONTHS AFTER VACClNATION, AMONG THOSE TuDERCUUN NEGATIVE (REACTION 0-7 MM) BEfORE 
VACCINATION AND AGED 1 MO TO 14 YR 
Tuberculin reaction size (mIn) Lesion size (mm) 
Production Date of ---­
labomtory Preparation Dose, 0.1 mg Dose, 0.01 mg Dose, 0.1 mg Dose, 0.01 mg 
and strain 
No Mean No Mean No Mean No Mean 
exam. size exam. sIze exam. size exam. size 
Cph 1331 Mar 68 42 14.5 59 9.9 255 5.8 262 3.7 
Cph 1173 Apr 68 31 15.0 27 10.9 237 5.4 190 3.7 
Cph 1331 Nov 68 32 13.8 17 10.5 379 4.8 379 3.1 
Cph 1173 Oct 68 57 15.5 60 12.8 409 5.2 375 3.6 
Cph 1331 Nov 69 5 16.2 R 8.1 218 5.4 216 3.6 
Cph 1173 Nov 69 2 14.0 4 9.0 125 5.3 127 3.6 
Mds 1331 Sep 68 18 12.7 15 10.2 67 4.7 57 3.3 
Mds 1173 Sep 68 6 18.7 9 9.4 73 5.1 75 3.4 
Mds 1331 May 69 11 11.5 23 8.4 144 5.1 190 3.2 
Mds 1173 May 69 10 14.0 9 9.8 201 5.4 192 3.3 
Mus 1331 Apr 70 17 5.5 12 2.8 
Mds 1173 Apr 70 16 5.2 13 1.6 
Total 214 14.5 231 10.6 2141 5.2 2088 3.4 
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into nine blocks, and one of these had 
already been included for the 10 per cent 
mndom sample referred to above. The 
eight remaining blocks were used for the 
present comparison). All children from 
this area were offered retesting after 12 wk 
to obtain a direct and precise comparison 
of the lwo supplies. (Since all children 
were offered the test, this area could not 
be included in independent retcslings at 
the later dates). The resulLs are given in 
Table 4 separately for each dose of each 
of the four batches. 
The tendency for the batches from 
Copenhagen to give a stronger response 
than the batches from Madras is so slight 
in magnitude that no biological signi­
ficance can be attached to it. In conclu­
sion, the resulls of both Tables 3 and 4 
indicate a high uniformity in the potency 
of the batches used, irrespective of pro­
duction laboratory or strain. 
A comparison of two batches in Danish 
school children - Of the three batches 
prepared in Copenhagen from strain 1JJ 1, 
the first (batch no. 28) and the third 
(batch no. 46) were assessed in luberculin­
negative, 7-yr old school children in 
Denmark. The tuberculin test both before 
and after vaccination was an intradermal 
test of 2 units of RT 23 with Tween 80. 
There-examinationwas carricdout 8-IOwk 
after vaccination. For balch 28, the mean 
reaction size (in 66 children) was 16.2 mm 
(standard deviation 3.9) while the BCG 
lesions averaged 6.0 mm. For batch 46, 
the mean reaction size (in 117 children) 
was 18.5 mm (standard deviation 3.7) and 
the mean lesion size 6.6 mm59>Go. (For 
a direct comparison of post-vaccination 
allergy in lndian and Danish children, 
using identical vaccincs and tuberculin in 
both places, see Valljshayee and asso­
cjates~l). 
In vitro quality control - In addition 
to the in vitro quality control tcsts done 
routinely at the production laboratories, 
it was decided to repeat these examina­
tions, for all the batches of vaccines used 
in the trial, elsewhere than in the pro­
duction laboratories. Randomly selected 
samples of all the six supplies were sent 
to different laboratories. These labora­
tories were instructed as part of their 
reference services for WHO, to carry out 
quality control tests. Tables 5, 6 and 7 
give the supply numbers and the names of 
the production and investigating labo-
TABLE 4 - COMPARISON OF THE FIRST SUPPLY FROM MAlJRAS AND SECOND SUPPLY FROM COPENHAGEN 
TN CffiLDREN OF AGE 1 MO TO 14 YR AND WITH AN INlTIAL TUBERCULIN REACTION OF 0-7 MM, 
IN 8 BLOCKS OF TRIVELLORE 
Dose, 0.1 mg Dose, 0.01 mg 
Production Date of 
laboratory and prepara- No MRS MLS No MRS MLS 
strain tion exam. (mm) (mm) exam. (mm) (mm) 
Cph 1331 Nov 68 318 17.6 5.0 317 12.6 3.4 
Cph 1173 Oct 68 252 17.9 5.2 271 14.6 3.6 
Mds 1331 Sep 68 305 16.0 4.9 277 13.2 3.5 
Mds 1173 Sep 68 25; 16.8 5.0 265 12.8 3.4 
MRS, mean reaction size; MLS, mean lesion size 
TARLE 5 - ESTIMATES OF VIABLE UKITS (MILLIONS PER ML) I"l L~lJORATORrESOUTSIDEa THE PRODUCTION LAIlORATORY 
c	 Investigating laboratory 
:;:, Product. lab. Date Date 
§: and strain of sample Moscow Prague Madras/Budapcstb Copenhagen 
rJ) prep. shipped'" I mgiml 0.1 mg/ml 1 mg/ml : 0.1 rug/ml 1 mgfml ; 0.1 mgfml 1 mg/ml ; 0.1 mg/rnJ 
Cph 1331 Mar 68 Apr 69 2.5 cfl.C 6.9 : 0.04	 8.6 - 6.0 : not done >-lc:Cph 1173 Apr 68 Apr 69 4.4 eft. 0.0 : 0.0	 5.4 - 7.8 : 0.4 -0.4 c;l 
t!1 
:;:;l 
nII Cph 1331 Nov 68 Apr 69 5.5 cll 1.5 0.008 6.0 - 5.3 : 0.6 -0.3 5.5 - 5.1 0.4 -0.6 c: 
t'"Cph 1173 Oct 68 Apr 69 4.3 cfl. 1.8 0.007 5.0 - 3.4 : 0.7 -0.4 8.2 - 8.7 0.7 -0.7 o 
'"r;; 
III	 Mds 1331 Scp 68 Apr 69 7.0 eft. 1.8 0.03 6.7 - 6.0 0.8 -0.5 5.7 - 8.1 0.6 -0.6 
";;j 
Mds 1173 Scp 68 Apr 69 11.0 eft. 3.2 0.000 9.7 - 6.7 0.7 -D.4 8.9 -13.1 0.6 -0.6 :;;J ttl 
-<ttl 
IV Cph 1331 Nov 69 Aug 70 2.48- 2.45 0.20-0.12 3.44- 2.63 0.16-0.06 2.10- 3.89 0.30-0.25 3.08- 3.28 0.24-0.26 Z 
.-1 
Cph 1173 Nov 69 Aug 70 2.53- 1.94 0.15-0.18 4.28- 4.57 0.31-D.30 4.55- 3.72 0.38-0.31 2.35- 2.20 0.22-0.22 ~ 
V Mds 1331 May 69 Aug 700. 7.08- 8.20 0.42-0.37 8.72-11.14 0.82-0.72 12.02-13.04 : 0.96-D.72 7.24- 7.06 0.66-0.59 >-l :;:;l
Mda 1331 ~[ay 69 Sep 70 9.08- 9.50 0.63-0.47 ;; 
Mds 1173 May 69 Aug 700. 5.80- 4.54 0.47-0.50 14.14-13.70 0.64-0.62 10.54- 8.66 : 0.62-0.59 5.66- 7.54 0.40-0.35 J" 
~Id8 1173 May 69 Sep 70 6.64- 5.30 0.47-0.47 ~ 
»­
Ij 
VI	 Mds 1331 Apr 70 Oct 71 6.56 0.53-D.50 13.06-10.84 0.85-0.73 6.34- 8.64 0.72-0.60 7.46- 6.60 0.51-0.65 :o:l >
Mds 1173 Apr 70 Oct 71 2.26 0.24-0.27 8.00- 9.12 0.50-0.58 2.14- 3.34 0.29-0.32 3.74- 3.70 0.36--0.32 '" 
UData for investigations in Copenhagen of batches prepared in Copenhagen are included for reference. The sample examined with
 
those shipped in April 1969 was taken from remaining stock in Copenhagen. For the samples shipped in August 1970, however Copenhagen
 
vaccine was returned from Madras, and tbe data shown refer to this returned sample; bIn this column, the upper half (vaccines prepared
 
1968, first 6 lincs) shows results from Madras, while the second half (last 8 lines) shows results from Budapest; CFar the first G batches,
 
Moscow reported "confluent growth" far the low-dose ampoules; dThe shipment sent in Aug. 1970 was 3 wk delayed during air transport.
 
Additional samples were thercfore sent in September 1970
 
..... 
-..j 
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ratories. The first three supplies were 
in April 1969 sent frol11 Madras to the 
BCG Laboratory in Prague and the BCG 
Control Laboratory in Moscow. Samples 
of the 3rd supply (produced in Madras) 
were also sent to the BCG Laboratory 
in Copenhagcn. In 1970 and 1971 
samples of the last three supplies were 
sent to Prague, Moscow, Budapest and 
Copenhagen. Thus in the case of the 
fourth supply (produced in Copenhagen) 
the vaccine was re-examined there after 
storage in Madras. 
Examinations of opacity and dry weight 
(desiccation till constant weight of BCG 
filtered off from the resuspended vaccine) 
were compatible with a 10:1 ratio for the 
two strengths. The actual data are not 
shown hcre. 
Reconstituted, undiluted liquid from 
placebo ampoules was seeded on solid 
egg medium. No growth of mycobac­
teria was observed. Tests of vaccines on 
several media showed no significant con­
tamination with microorganisms other 
than mycobacteria. 
Results of viability tests are shown in 
Tables 5,6 and 7. In Table 5 estimates of 
viable units based on counts of colonies 
on solid media (L-J, Ogawa) are shown 
in terms of millions per fill of the COl1cen­
trations used in the field trial. In many 
cases, laboratories made two estimates 
for each sample. Sueh double estimates 
are shown with a hyphen. Table 6 shows 
the oxygen-uptakc, a test of the enzymatic 
activity of the live BCG organisms, mea­
sured in a Warburg apparatus. Table 7 
shows the germination rate, whi<.:h is a 
semiquantitative estimate of the per­
centage of bacilli that are judged to have 
started germinating, by observation 
through the microscope of live BCG 
seeded 1-4 days ago on solid medium. 
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TABLE 6 - ESTIMATES OF OXYGEN UPTAKE IN 
LADORATORms OUTSIDEa THE PRODUCTION LABO­
RATORY 
Supply 
No. 
Product. 
Lab. and 
strain 
0. uptake (1'1) 
of 30 mg BCG 
during 1 hr 
0. uplake (1Jo1) 
of 20 mg BCG 
during 3 hr 
Prague Madras Copen­
hagen 
I Cph 1331 
Cph 1173 
18-23 
13-16 
36 
26 
Cph 1331 27-26 
Cph 1173 21-19 23 73 
II	 21 38 
III	 Mds 1331 11 9 25 11 
Mds 1173 15-13 25 34 
iV	 Cph 1331 25 49 
Cph 1173 18 34 
V	 Mds 1331 23 17 
Mds 1331 23 
Mds 1173 i5 11 
Mds 1173 11 
Vi	 Mds 1331 Not available 18-21 
Mds 1173 13 26-26 
a'b as in Table 5; Details of sample, mgjml pre­
pamtion and shipment same as in Table 5 
For a further description of these various 
methods see WHO/TB/Techn. Guide/ 
77.9	 (Ref. 62). 
In judging the data on viability, the 
relative crudeness of these methods should 
be kept in mind. The colony counts do 
not measure number of bacteria, but 
number of 'units', i.e., bacteria or clumps, 
ond is thus strongL dependant on the 
deggree ro clumping. The assesssment of 
aermination is free of this objection, but 
is at the same time a more subjective 
method. The estimation of oxygen­
uptake (which can be rather precise if 
carried out on large samples) is in this 
"Estimated percentage of germinating mycobacteria out of total. [<'or intervals with one limit 
in bracket, the estimate is closer to the limit not in bracket; 
b'o as in Table 5; Details about sample (mg/ml) preparation and shipment same as in Table 5 
case somewhat imprecise bccause only a 
limited number of vaccine ampoules 
could be used for each test. 
For the samples shipped in April 
1969, there seem to have been mishaps 
in estimating viable units, in both Moscow 
and Prague (Table 5). In Moscow the 
weaker vaccine gave confluent growth, 
although the stronger gave results as 
cxpected. The most obvious explanation 
is a systematic mistake in the specification 
of the dilution procedure. In Prague, 
the results are very variable, and the weak 
vaccines disproportionately weaker than 
the strong vaccines. Some were without 
growth. Very likely, the colony count 
system failed because of a faulty solid 
medium. Fortunately the Prague Labo­
ratory made at the same time determina­
tions of oxygen uptake and germination 
rates, and these results are quite within 
the expectcd range. It should further be 
noted that the second supply (produced 
in Copenhagen) gave adequate colony 
counLs in Madras, and that the third 
supply (produced in Madras) gave ade­
quate colony counts in Corcnhagen. 
For all other vaccines, the estimates 
obtained are compatible with the assump­
tion that the vaccines were of uniform 
strength. This agrees with the rather 
uniform post-vaccination allergy (Tables 
3 and 4), and there is thus a priori no 
reason to analyze the trial separately 
either for various batches or for each of 
the two production laboratories. 
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6. Tuberculins 
The nomenclature for skin test 
materials from mycobacteria for demons­
tration of delayed hypersensitivity is still 
not clarifled. I t is generally agreed that 
M. bovis and M. al'ium are species in 
their own right and not sub-species of 
M. tuberculosis. Thus it does not seem 
reasonable to talk of, e.g., avian tuher­
culin. Yet an International Standard 
for avian tuberculin is still in existence. 
Runyon63 has proposed 'myeobaeterins' 
as a comprehensive name for all these 
substances. 
In the earliest studies of low-grade 
sensitivity24'64>G;; (for a review sec Edwards 
and Edwards66), use was made of different 
doses of tuberculin (c.g., 5 units and 100 
units) and quantitative measurement of 
reactions. Palmer ancl Strange Petersen23 
suggested that reactions must be taken to 
be nonspecific if they are weak or if they 
can be elicitecl only with a strong dose of 
tuberculin; also, that spednc and non­
specific reactions are often overlapping, 
so that reactions of intermediate size 
cannot be c1assined (also sec Nyboe2~). 
The introduction of double testing with a 
tu berculin ancl simultaneously with a 
myeobacterin prepared from a different 
mycobacterial species 29,32,67,68 appeared 
to be a significant improvement, as shown 
by Edwards and co-workers68 in their study 
of such double testing among patients. 
Tuberculin---There can be little doubt 
that the batch of tuberculin named PPO-S, 
prepared by Seibert and co-workers in 
1939 hy prccipitation with ammonium 
sulphate69, is superior to the other avail­
able tu berculins. It appears to be slightly 
more specifIc than acid-precipitated tuher­
culin7 0 and to be less prone to adsorption71 • 
A part of the original PPD-S was used by 
Palmer and co-workers in their many 
epidemiological studies; dilutions made 
from this part (supplied by the Antigen 
Production Laboratory, Atlanta) were 
also used during the earliest phase or the 
present trial. Another part of this batch 
was adopted as the International Standard 
for Purified Protein Derivative (PPD) of 
Mammaliau Tubereulin72. Two ampollles 
of this tuberculin, each ampoule contain­
ing 2,500,000 IU, were made availahle 
to the study. These were reconstituted, 
diluted in phosphate buffer (pH 7.25), 
dispensed in ampoules and again freeze­
dried (in the BCG department, Statens 
Seruminstitut, Copenhagen) each am­
poule containing 500 IU and 1/6000 g 
mole phosphate butTer salt. 
Mycobacterin - Based on a number 
of unpublished pilot studies it was felt 
that myeobacterins prepared from avian, 
Gausse or Battey strains would all serve 
equally well as a choice for atypical myco­
bacterin. The decision to usc PPO-B, 
preparcd from an atypical strain from the 
Rattey hospital, USA (now identified as 
M. imracel/ulare), was based mainly on 
the consideration that there was already 
extensive epidemiological and clinical 
experience with thi preparutio(l7:l. While 
the American authors have tended always 
to compare equal doses by weight of 
dilTerent mycobacterins it was decided for 
the present purpose to use the strongest 
acceptable dose of PPD-B so as to reveal 
even weak degrees of sensitivity. Thus 
it was decided to use 10 'units' of PPD-B 
in the study, rather than the 5 'units' 
previously used by Palmer. 
Products and dosages - Four lots of 
PPo-s and eleven lots of PPD-B were 
used in tile trial. During the first 6 
months of the trial, PPD-S was supplied 
from Atlanta, Georgia, USA, in ready­
madc dilution with a nominal content of 
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0.0001 mg or 5 'units' per 0.1 ml. During 
the remaining two years of intake the 
International Standard was supplied from 
Copenhagen in ampoules each contain­
ing 500 IV. 
Before using the tuberculin from 
Copenhagen it was compared with the 
tuberculin from Atlanta. The results arc 
shown in Tables 8 and 9. It will be 
observed that 5 IU, in freeze-dried form, 
received from Copenhagen was stronger 
than 5 'units' of PPD-S ready-made 
solution received from Atlanta. So the 
comparison was repeated, this time using 
2.5 IV from Copenhagen against 5 'units' 
from tIanta. The latter was now slightly 
stronger than the former. It was there­
fore decided to use 3 IU from Copenhagen 
as an equivalent dose to 5 'units' from 
Atlanta. 
PPD-B supplied from the Antigen 
Production Laboratory, Atlanta, was 
used in the trial except during the last 
3 months. For the major duration of 
this period, batch 1006 L6, lot II was 
used. During the last 7 months, PPD-B 
prepared from batch Poly D, lots IV-VI 
was used. The results of a parallel line 
assay showed that they wcre not different 
in potency. On two occasions when 
shipments of PPD-B from Atlallta were 
delayed, an available supply of freeze­
dried PPD-B with gelatine was used for 
short periods. PPD-B (poly B) in freeze­
dried form was used towards the end of 
the intake for about 3 months. Most of 
it was freeze-dried in Copenhagen but 
some in the BCG Laboratory in Madras. 
Before using the freeze-dried PPD-B 
from Copenhagen, comparison was made 
between this and the one in dilution 
received from Atlanta. Correlation of 
reactions among indviduals simul­
taneously tested with the same doses by 
weight, showed practically no difTerence 
between the two preparations. It was 
therefore decided to retain the same dose 
by weight for freeze-dried PPD-B also. 
Possible variation among the different 
lots of tuberculin as well as PPD-B was 
examined in yet another way. The mean 
size of reaction in 4 categories of persons 
were plotted for each panchayat arranged 
in time order as shown in Fig. 2. Pan­
chayats where more than one lot has been 
used, have been left as gaps. Supplies 
of new lots have been shown as vertical 
continuous lines for lots of PPO-S and 
vertical broken lines for lots of PPO-B. 
It is seen from Fig. 2 that although there 
is varia lion in tuberculin response in 
different parts of the trial area, these 
changes can 110t be identified with change 
of lots. Thus it was confirmed lhat the 
potency of the difTcrcnt lots of PPD-S 
and PPO-B used was uniform. 
7.	 Study area 
The area selected for the study included 
209 contiguous panehayats and one town, 
with a total population of about 360,000 
perf>ons in Chingleput District of Tamil 
Nadu State in south India. Chinglcput 
District with an area of 8170 km 2 and a 
population (1971) of about 2,900,()()O is 
situated on the east coast. Administra­
tively the district is divided into seven 
taluks. For further administrative and 
developmental purposes a taluk i.s divided 
into 3-5 panchayat unions, each with 
40-70 panchayats. Each panchayat 
(commune) consists of one or marc 
villages with their hamlets with popu­
lations from bclow one thousand to several 
thousands. 
The study area selected included the 
whole of Trivellore Taluk (comprising 
Kadambattur, Trivellore, Poondi and 
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TABLE 8 ­ REACTIONS TO 5IU OF PPD FROM COPENHAGEN ANO 5 "UNITS" OF PPD-S fROM 
AMONG PERSONS AOED 10 YR OR MORE 
ATLANTA 
Reaction (in nun) to 5 "nnils" of PPD-S (from Atlanta) 
Date of preparation: 10-6-68 Total 
o 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32-r 
0 11 3 4 2 21 
2 1 2 5 2 10 '" 
4 2 7 10 18 39 '" 
6 .3 7 9 7 29 '" C 
0 
011 
'" 
'" 8 2 3 4 6 [6 
-g'" '" 
0. 10 10 2 1'" 14 
u 
E 12 3 6 3 2 3 1 19 '" S 14 4 3 5 4 4 1 22Q 
0 
'" 0...00 
0... O'? 16 3 6 4 7 8 4 7 2 42<-.0\ '"
 o ~-
'"
;:J~ 18 5 7 14 8 2 2 41
............
 
'" .. 
0-0 20 10 13 5 9 4 45
- '" '".-..'~ 
8"9 22 3 8 10 6 (i 6 426 ~ 
c: &l '" 
e.~ 24 6 3 3 8 3 25c: '" 
.g 
rj 26 2 7 5 I 15
... 
'" 
'" '" ~ 
28 2 6 2 10 
30 
'" '" 
'" 
32+ 1 
Total 15 17 39 64 32 18 23 18 40 41 17 27 26 2 391
" 
Ellapuram panchayat unions) and part of 
Tirutlani Taluk (Tiruvalangadu pan­
chayat union). Situated in the study 
area is the town, TriveIIore (40 km west 
of Madras City), with a population of 
about 25,000. For operational con­
venience of the trial, the town was divided 
into nine blocks. .for thc purposes of 
this trial the panchayat was taken as the 
main population unit. 
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TADLE 9 - REACTlON TO 2.5 TU OF PPD FROM COPENHAGEN AND 5 "UNITS" OF PPD-S FROM ATLANTA 
AMOl\G PERSONS AGED to YR Ok MORE 
Reaction (in mm) to 5 "units" of PPD-S (from Atlanta)
 
Date of preparation: 10-6·68 Total
 
o	 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32~ 
4 2 3 30"	 13 
"­2 2 6 12 4 25 
4 2 3 13 15 4 2 4 44 " 
"­6 4 6 12 4 3 31 
.--­
<:l 
''> R 2 4 4 1 2	 13cO " rn 
..c 
'" 10 1" "- 4 2	 78­0 
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"­S 
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..... N	 " 
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"­
"­32+	 2 3
"­
"­Total 4 14 33 33 26 11 20 26 30 35 34 56 49 26 11 3 2 413 
Each panchayat and town-block was 
given a three digit number, the first 
digit identifying the panchayat union and 
the next two identifying the panchayat 
or the town-block within the panchayat 
union. Fig. 3 shows the trial area divided 
into panchayat unions, their respective 
pancbayats, and other salient features. 
Over 60 per cent of the population in the 
study area depend on agriculture based 
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Fig. 3 - Map showing the BeG trial area 
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on seasonal rains, the other main occu­
pation being small household industries. 
There are no parennial rivers in the area 
and the main-stay of irrigation are wells 
and dammed water reservoirs. The alti­
tude is approximately 50 m above sea 
level. 
Besides tuberculosis, there is a high 
prevalence of leprosy and filariasis among 
the population. There arc 12 health 
facilities run by the Government of Tamil 
Nadu in the area. Of these, one is a 
hospital with 60 beds at Trivellore; the 
rest offer mainly outpatient care and 
carry out public health activities. There 
is also a church-managed hospital. Private 
practitioners of modern medicine are less 
than a dozen and are mainly in the town 
and two larger villages. There usually is, 
in every major village, at least one practi­
tioner of indigenous medicine. 
8. TIle intake 
Intake was started in July, 1968, after 
completion of the preliminary investi­
gations comprising selection of area, 
selection of biologicals and training of 
personnel. During the pre-intake period, 
10 manuals* and work instructions, with 
concommitaot cards and forms, had been 
.developed and extensively tested. The 
intake lasted 2 yr and 8 mo and was 
completed in March, 1971. 
The intake comprised the following 
main activities: (I) a complete eensus 
of the population; (2) skin testing 
for delayed hypersensitivity, vaccination 
(vaccine or placebo), and X-ray examina­
tion; (3) reading of skin test reaction; 
*Manual for tcstcrs and vaccinators, manual 
for census takcrs, instrnclions for filling the ondi­
vidual card, mannal for recording names, manual 
for X-ray lechnicians, manual for X-ray reading 
manual for spUlum collection 
(4) X-ray reading; (5) collection of 
sputum samples 1'1'0111 those identified as 
eligible on the basis of X-ray results; and 
(6) bacteriological examination of spu­
tum samples. 
Prior to starting the work in the area, 
public cooperation was sought by contact­
ing all officials and other persons who 
could assist in obtaining cooperation of 
the people. The nature of activities and 
the services provided were carefully ex­
plained with emphasis on the caseflnding 
activity. In addition, just before taking 
up each panchayat, a visit was made by a 
team leader to each village, when a rough 
map of the panehayat was drawn after a 
survey of the village. 
The statistical section of the project 
supplied to the field teams individual 
cards-TPT 69 (Fig. 4)-eaeh card 
marked with a random digit out of the 
numbers], 2, 3 (for the purpose of random 
allocation of vaccines and placebo). The 
field teams stamped seven-digit individuals 
numbers on these cards in the order in 
which the cards were received. The first 
three digits indicated the panehayat union 
and the panchayat within the panchayat 
union and thc next four a serial number 
for each person in the panchayat. 
Independently of the individual numbers 
each household was given a household 
number which was painted on the door­
post. 
Census ofthe population - Census was 
carried out on a household basis visiting 
each housc in a systematic manner, so 
as not to miss any. A 'household' was 
defined as a group of persons who live 
together and have their main meals pre­
pared in the same kitchen. 
Census of each household comprised 
of obtaining the full composition through 
careful interview of the head of the house­
' ..... froh). • A'l Q CCflo 50t 
E, 07 w-s~1 V 
o. .. 
(II) 40 KAN])H uR-
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hold or a responsible member, and recor­
ding, on individual cards, identification 
particulars viz., name, father's or hus­
band's name, relationship to the head 
of the household, age, sex, occupation, 
census status, and if an individual had 
gone to another place, the place he has 
gone to-or if he were a visitor, the place 
he belonged to (for this the census taker 
was provided with a list of panchayats 
and villages in the study area). The 
members of a household would usually 
but not always be registered in a logical 
order with consecutive individual numbers. 
Some important aspects of census are 
given below. 
Name - All interviews for census had 
to be conducted in the regional language­
Tamil. Since the statistical machinery 
is based on English' rather than Tamil 
letters, the names had to, be recorded in 
the English alphabet. While Tamil is 
phonetic, English is not, also not when 
used for spelling of Tamil names. To 
permit alphabetical sorting and listing 
of names it was then necessary to intro­
duce a standardized spelling. For this 
purpose a standard list of 300 common 
names in the area was prepared, on the 
basis of which spelling of any other 
name could be deduced. Thus the spelling 
'Muurthi' was used also for a literate 
person who might himself spell his name 
'Moorthy' or 'Murti'. Surnames (caste 
names) were mnemonically coded into 
three letter codes. The name was recorded 
in box I. 
Relationship: Relationship to the 
head of the household was recorded 111 
box 8. Head of the household is a 
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Fig, 4 - Individual card (TPT-69) 
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member of the household who is rccog­
nised as such by the other members of the 
household. He was identified as A and 
his wife as W (or if A was female, her 
husband as H). Brothers in the order 
of descend ing age were recorded as B, C, 
D, E, sisters as S, T, U, V, father F and 
mother M. Sons were indentified as 
I, 2, 3, 4 or 5 and daughters 6, 7, 8 or 9. 
For example, 6-H-S would mean 'the 
sisler-in-Iaw of the eldest daughter of the 
head of the household'. In such a manner 
even the most complicated relationships 
{:ould be coded and recorded. Codes 
also exist for homeless persons and 
visitors. 
Census stalus : Census status was 
recorded, in box 9, as a single letter: P 
for a resident presen t at the time of census; 
A, absent resident; V, visitor staying over­
night in the household; X, a casual visitor 
only, etc. (Similar but other codes exist 
for follows-up census status e.g., B for 
new-born; F, fate unknown). 
Age: Age (recorded in box 13) if 
stated by a person was taken as the correct 
age. In many instances, the individual 
was unable to state his or his child's age. 
In these instances age was estimated after 
having a look at the pcrson. In the words 
of the manual "the estimation is done hy 
<:ross-examining the person, or in case of 
infants, the parents, with reference to 
important happenings in the past". For 
<:hildren aged below one yr, age was 
recorded in months and for the rest, in 
completed years. 
Testing with PPD-S alldPPD-B, 'vacci­
nation', finger-printing and X-ray exami­
nation -- An Examination Centre was set 
up at a convenient place in the village, for 
conducting tuberculin tests, 'vaccination', 
and X-ray examination. All individuals 
for whom the census was completed were 
sent to the examination centre with a 
chit showing their household numbers ; 
the individual cards were never given to 
the persons but taken to the X-ray cenlre 
by one of the learn-members. 
At the examination centre, the identi­
fication particulars, I.e., name, age, sex 
ete. of each individual were verilled and 
the left shoulder examined for sears 
indicative of previous BCG vaccination. 
Skin tesling with PPD-S and PPD-B 
was offered to all individuals aged one 
year and above. The lests were given 
intradermally in the mid-dorsal aspects 
of the forearms. To avoid 'psychological 
bias' in reading of the reactions, the 
two tests were allocated randomly to 
right and left forearms, according to the 
last digit of the individual number being 
even or odd. Each tester was assisted by 
a clerk who would dictate the combina­
tion, check that it was correctly foHowed, 
and record accordingly. 
'Vaccination' (i.e., vaccine or placebo) 
was offered to all individuals aged one mo 
and above. The vaccinator would use 
one box with three ampoules at a time, 
and would vaccinate the individual from 
the ampoule with the suffix (J, 2, or 3) 
corresponding to the random digit pre­
viously entered in the individual card. 
Also, the vaccinator had a clerk who 
would dictate the ampoule to be used, 
and check and record the ampoule number. 
From the time the vaccine was manu­
factured till it was actually used in the 
field it was kept under refrigeration at 
4 0 _8°C. In the field, to protect the vaccine 
from heat and sunlight, special precaut­
ions were taken : The vaccine ampoule 
was kept immersed in icc, in a closed 
insulated jug, right up to the moment of 
filling the syringe. Also, the syringes 
used for vaccinations were covered with 
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specially designed rubber tubings. Further 
-more, most vaccinations were carried out 
around sunset or later, or, if occasionally 
earlier, invariably in the shade. 
Finger prints were taken on the reverse 
of the individual card immediately after 
'vaccination'. For individuals aged 5 yr 
and ahove one dab and one roll fmger 
print of the left index finger, and for 
children aged below 5 yr, a left palm­
print were taken. (When a new case of 
tll berclllosis was diagnosed in the follow­
up of the population, the finger print 
obtained at the time of sputum collection 
was compared with the finger print 
obtained at the time of vaccination, as 
a final proof of the identity of the indi­
vidual). 
X-ray examination - All individuals 
aged 10 yr and abow were eligible for a 
chest X-ray, 70 mm photofiuorogram, 
postero-anterior view. The X-ray units 
operated on storage batteries and, being 
mounted in sturdy vehicles, could reach 
almost all villages in the study area. A 
clerk noted down, for each X-ray roll, 
individual numbers in the order of ex­
posure. The individual number as stamp­
ed on the individual card of the person 
X-rayed was exposed on his photofilloro­
gram. 
Reading of skin test reactions - Be­
cause of the size of the study population 
and the duration of the intake it was 
necessary to employ more than one tuher­
culin reader. To ensure a uniform quality 
of readings the readers were intensively 
trained and standardised before they were 
introduced into the study. The standar­
dization was in terms of intra and inter­
reader consistency. Systematic periodical 
assessment of the readers ensured the 
continued uniform quality of readings. 
Reading of the skin test reactions, in 
terms of transverse diameter of induration 
in mm, was carried out usually after 
three days, occasionally after four days, 
and in exceptional cases after two or five 
days. The reader and a clerk went [rom 
house to house. The reader dictated the 
size of reactions in right arm and left 
arm in that order to the clerk, who 
repeated and recorded the mea urements. 
The rcader would thus not know the order 
in which PPD-S and PP -B had been 
allocated to the right and 1 ft forearms. 
X-ray reading - The photofluoro­
grams were processed at the fIeld head­
quarters and read by two X-ray readers 
independently and 'blindly' at the project 
headq uarters. The readers (there were 
several during the study, because of 
changes in personnel) were physicians 
already specialised in chest diseases, and 
were further given training in reading 
70 mm films. 
The reading was recorded by the reader 
only if abnormal, according to the follow­
ing code. The individual numher as 
seen on the film was also recorded. 
O.	 Exposure technically inadequate 
Extra	 respiratory 
J. J	 Cardiac abnormality 
1.2	 Vascular abnormality 
1.3	 Bony abnormality (e.g., scoliosis) 
Respiratory, definitely extra-pulmonary 
2.1	 Very dense spot or spots iu hilar 
region (caJcifkations) 
2.2	 Obliterated costo-phrenic angle 
and/or pleural scar and/or 
pleural calcification 
2.3	 Evidence of chest surgery 
2.4	 Enlarged mediastinal and/or 
hilar glands 
2.5	 Basal-parietal opacity, indicative 
of pleurisy with effusion (in any 
area) 
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2.6	 Pneumothorax or hydropneumo­
thorax 
2.7	 Special pathology not specified 
above 
Special patterns 
5.1	 Uniformly dense, round opacity, 
single or multiple (c.g., cyst) 
5.2	 Atelectasis 
5.3	 Consolidation 
5.4	 Less dense opacity combined 
with cardiac abnormality (6 and 
1.1 both present in one person) 
Opacity or opacities in lllnti field~ 
3 Very dense and very well demar­
cated (e.g., calcification) 
4 Dense and well demarcated (e.g., 
fibrosis) 
6 Less dense opacity, or less well 
demarcated (e.g., infiltration) 
7 III-demarcated or doubtful cavity 
8 Well-demarcated cavity or cavi­
tics, each less than 4 cm (less 
than 6 mm on thc 70 mm film) 
9	 At least one well-demarcated 
cavity more than 4 cm (more 
than 6 mm on the 70 mm film) 
In case of multiple lesions, only the 
most serious was recorded. For the 
reading, 3,4,6,7,8 and 9 above, a second 
digit was recorded, as follows: 
Location 
Total extent of 
opacities Single More Both 
opacity opacities lungs 
in one 
lung only 
Less than one square 
centimeter (1.5 mm" 
on the 70 rrun film) 
or linear bands 2 3 
Less than one sixth 
of total area of lung 
fields 4 5 6 
More than one sixth 
of total area of IUllg 
fields 7 R 9 
Small spots, widely 
disseminated in 
both lungs o 
For a first digit reading of I -9, the 
following alphabets were used as a third 
code (except calcification). 
A - Abnormallty othcr than tuber­
culosis; 13 - Tuberculosis, inactive 
C - Tuberculosis, possibly active; 
D - Tuberculosis, probably active. 
It may be noted that the above alphabet 
code has been used systematically in most 
Indian epidemiological mass surveys since 
1955. 
Umpire readings - The photofiuoro­
grams of all persons read as 'C' or 'D' by 
one of the two readcrs only, and those of 
persons whose sputum samples were 
positive on direct microscopy but negative 
on cultnre were reassessed by a third 
(umpire) X-ray rcader. 
Sputum collection - Individuals whose 
photofluorograms were classificd as 
codes 5 to 9, or Cor D even if not 5 to 9, 
by either reader were eligible for sputum 
examination. For all such individuals, 
the individual numbers were listed and 
sent to the field. 
From each eligible individual, attcmpts 
were	 made to collect two samples of 
sputum, one a supervised 'spot' sample 
and the other, an overnight 'collection' 
sample. The spot sample was collected 
during the first visit of the sputum collector 
to the household of the individual, and 
the collcl:tion sample at the second visit, 
the next morning. If for any reason the 
collection sample was either not satis­
factory or not obtained, a second spot 
specimen was collected. Whenever a 
specimen of sputum was classified as 
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'contaminated' on culture, attempts were 
made to obtain a third sample of sputum. 
All precautions were taken to establish 
the correct identity of digible persons as 
also to see that the sputum specimens were 
as far as possible obtained from the bron­
chial trec and not mere saliva. 
Sputum samples werc coIIected in 
stcriliscd universal containers with alumi­
nium screw caps. Thc bottles were 
supplied to the Held teams by the labo­
ratory (Union Mission Tuberculosis 
Sanatorium Laboratory, Madanapallc, 
initially and latcr Tuberculosis Research 
Centre Laboratory, Madras). These bottles 
had serial numbers cngravcd on the screw 
caps, e.g., E 001 to E 999 etc. At the 
time of sputum collection the bottles 
were used at random and not strictly 
according to serial order. 
All sputum samples were stored under 
refrigerated condition from the moment 
of collection and transported under 
refrigeration till delivery to the bacterio­
logical laboratory. 
Bacteriological examination of sputum 
specimens - Sputum specimens were re­
received at the bacteriological laboratory 
along with a form indicating the number 
of bottles and the dates of collection. 
The laboratory did not get the individual 
number or any other particulars along 
with specimens, except the 'bottle number' 
that was engraved on the screw-cap. The 
laboratory forthwith allotted a 'laboratory 
number' of its own to cach specimen, 
recorded the bottle number and the res­
pective laboratory number for each speci­
men in a register. 
The following examinations were 
carried out for each sample: 
Smear examination by fluorescenoe 
microscopy after staining a heat fixed 
smear by auramine phenol stain. The 
results were recorded and later directly 
punched in terms of cither actual number 
of bacilli in the whole smear if not above 
99, otherwise as 1--I- to 4-1-. The informa­
tion was reclassed by computer as follows 
(number of acid-fast bacilli seen) ; 
0, no acid-fast bacilli seen; I, 2, 3, 
4, 5, 6-11, 12-24, 25-49, 50-99 
:> lOO/smear, 1-5/low power field (1+); 
6-100/low power field (2-1-); > lOO/low 
powcr Held but< 100/high power Held 
(3 +); :> 100/high power field or clumps 
(4+) 
with additional classes for results not 
available. 
Sputum Culture-To 5 ml of a sputum 
sample, an equal volume of 4 per cent 
NaOHwas added, shaken in a mechanical 
shaker for 20 min and centrifuged at 4000 
rpm for 20 min. The supernatant fluid was 
carefully decanted and the deposit resus­
pended in sterile distilled water, reeentri­
fuged and the deposit inoculated on 2 
slopes of Lowenstein-Jcnsen (L-J)medium. 
The inoculated bottles were incubated 
for a maximum period of 9 wk. The 
bottles were examined every week for 
8 to 9 wk unless a 'positive' or 'contami­
nated' result was obtaiued in the mean­
time. Culture bottles which did not show 
any growth at the end of 8 wk were 
reported as 'negative' and discarded. 
All positive cultures were examined by 
an independent person for morphological 
characteristics for classification as 'typical 
tubercle bacilli' indicating M. tuberculosis 
(or M. hOllis). Microscopic examination 
was performed on the bacilli from all cul­
tures of doubtful colonial morphology and 
those which did not show acid-fast bacilli 
were discarded as contaminants, the rest, 
which showed acid-fast bacilli. reported 
as strains ofatypical morphology. 
Culture results were reported quantita­
31 TUUERCULOSIS PREVENTION TRIAL, MADRAS 
tively in terms of number of colonies 
(up to 49 colonies), or I -1-(50-100 colonies), 
2+ (more than 100 colonies), or 3+ 
(confluent growth). Out of the two slopes, 
the one with the higher growth was repor­
ted. The results were punched directly 
and reclassed by computer as follows: 
no growth; growth ill water of conden­
sation; I colony; 2 colonies; 9 colonies; 
10-14; 15-19; 20-24; 25-49; 50-100; more 
than 100 discrete colonies; confluent 
growth; 
with furthcr classes for contamination 
and other special cases. 
Druf: sensitivity tests : The following 
drug sensitivity tests were carried out on 
all strains with typical morphology. The 
standard scnsitive strain H 37 Rv. was 
tcstcd with each batch of culture. The 
following drug slopes were used: 
Drug Slopes containing 
(p.g per ml) 
Streptomycin 8, 16, 32, 64 
Isoniazid 0.1, 0.2, I, 5 
Para-nitrobenzoic 500 
acid (PNB) 
However, the PNB sensitivity test was 
not used in Madanapalle, where instead 
a catalase test was carried out. Up to 
March 1972, three weaker dilutions were 
used in addition for streptomycin and two 
for isoniazid, and PAS sensitivity was 
tested for 6 different concentrations. 
After sensitivity test readings, the 
minimal inhibitory concentration (MlC) 
values wcrc determined using a 20-colony 
end-point. Isoniazid sensitivity was re­
ported as MIC while those of streptomy­
cin and PAS as resistance ratios (RR). 
The niacin test was performed on one 
of the control slopes from the drug 
sensitivity tests. Each bottle was flIst 
inspected for the prcscnce of water of 
condensation; 0.5 ml distilled water was 
added to each culture bottle which had 
scanty or no water of condensation, and 
the culture bottle autoclaved. About 
0.25 ml of the resultant extract was 
transferred to a test-tube, and 0.25 ml 
of 3 per cent alcoholic benzidine solution 
followed by 0.25 ml of 10 percent aqueous 
cyanogen bromide solution were added. 
The results were reported as follows ; 
Pink or red prccipitate 2+; Faint 
pink prcdpitate 1+; White precipitate W. 
Growth at 25°C : The number of 
colonies were reported as for the primary 
cultures above. However, for the analysis 
of the present report cven one colony was 
taken as 'growth'. 
Definition ofa strain ofM. tuberculosis­
Based on past experience ofthe laboratory, 
strains of M. tuberculosis were defined 
according to the flow-chart, shown in 
Table 10, wbich was part of th computer 
program. It will be noted that particular 
weight was given to the niacin reaction. 
Othcr tests came in mainly when the 
niacin test result and the PNB sensitivity 
were not available, as might happen es­
pecially if the secondary cultures failed. 
Figures given in parenthesis in Table 
10 show the proportion of cultures falling 
into each class of the table. These figurcs 
are based on a sample of about 7200 
cultures. It is observed that, although 
the classification chart provided decisions 
for all combinations of results almost all 
thc cultures that were classified as 
M. tuberculosis were niacin positive. 
Runyon's classification - The class 
U M B is a mixture of well-classified strains 
other than M. tuberculosis, and of strains 
not definitely classifiable. Further analysis 
of the class UMB is not attempted in this 
report, although the laboratory on the 
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TABLE 10 - CRITERIA FOR CLMSIl'TCATION OF MYCOBACTERIAL STRAINS AS M. lubl!rculosis (M. Tltb) 
OR UNIDENTIFIED MYCOBACTERIA (UMH)'" 
Colony morphology Colony morphology : 
Results of Niacin 'typi(;al' 'atypical' or not available 
PNB (++) 
Niacin Niacin Niacin Niacin Niacin negative 
(+) not done negative (+) or not done 
Sensitive M. tub M.lub M. rub (a) .70,1. tub UMB 
(57.2) (0.2) (0.0) (0.0) (-) (0.3) 
Not done M.lub M. rllb (b) TIMB (c) UMn 
(0.1) (-) (2.5) (-) (-) (2.6) 
Resistant M.lltb M. tub UMB UMD UMn UMB 
(0.4) (0.0) (-) (0.9) (0.1) (35.7) 
Figmes in parentheses give percentage of cultures falling in each class; (-) indicates no 
frequency and (0.0). <0.5 per cent (a) If > 10 colonies: go to (d); otherwise: go to (e); (b) 1f 
> 10 (;olouics : M. IItb.; otherwise : UMB; (c) If photo chromogen, scotochromogen or rapid 
grower: UMB; otherwise go to (e); (d) If growth at 25°C: UMB; otherwise (no growth or not 
done) : M. I/lb.; (5) If no growth at 25°C; M. lub.; otherwis~ (growth or not done) ; UMB 
"Unidentified mycobacteria includes sueh strains as are often referred to as 'atypical', as well 
as unclassifia ble strains 
basis of pigmentation and other criteria 
reported classification mainly according 
to Runyon. 
9. Record linkage at iota	 e 
In a long term prospective study such 
as this, data for each indiviuual arc collect­
ed at different places and at different 
points of time requiring the application 
of the concept of 'record linkage'. With 
the large volume of data, such linkage 
would bc l:xtremely difficult if not impossi­
blc without the use of data processing 
machinery. It is also essential that there 
should be rigiu rnles for recording in 
fIeld and laboratory which permit direct 
transfer of data on to punch cards without 
coding or copying by hand. Given below 
are some of the essential details of the 
different records used, transferring of 
data from records to punch cards and the 
record linkage achieved through data 
processing machinery. It will be noticed 
that there was virtually no manual coding 
or transfer of data from one record to 
another and data once collected was 
directly transferred on to punch cards, 
verified and for each individual all data 
linked by machinery. 
Records - During intake, data for 
each individ ual was collected on one or 
more (depending upon the eligibility of 
the individual for uiffcfl:nt examinations) 
of the following 5 types of reeorus, each 
independent of the others. 
(i) Individual card (from the field) 
showing identiflcation particulars 
(such as name, age, sex etc.), 
tuberculin test results, code of 
BeG vaccine, X-ray roll number 
and sputum bottle numbers; 
(ii) X-ray	 report (from the X-ray 
reader); giving the results of the 
X-ray; 
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(iii)	 Report giving sputum smear 
results (from the laboratory); 
(iv)	 Report giving sputum cullurc re­
sults (from the laboratory); 
(v)	 Report giving the results of 
identification and drug sensitivity 
tests (from the laboratory). 
The field teams ensured that the 
individual cards were complete and correct 
before they were sent to the statistical 
section at headquarters. Otherwise 'field 
statistics' were avoided as far as possible, 
and speedy punching and checking of 
punched data relied upon to reveal omis­
sions and errors. A routine was 
therefore introduced whereby, for each 
type of record, the presence of those 
kinds of errors and inconsistencies that 
were known to occur occasionally were 
checked systematically on the machine 
at the earliest possible moment and the 
data amended, wherever possible. 
j\1achinery -Throughout the period of 
intake processing of punched cards was 
done on a tabulator (IDM 447) along with 
reproducing punch, collator and sorter. 
Funch codes - With a tabulator and 
a mechanical sorter the standard 80­
column punch-card limits llexibility 
where the information for a single person 
may fill several such cards. Very careful 
attention was therefore given to the cons­
truction of punch codes, both in terms of 
condensation of information and in 
terms of compatibility of cards with diffe­
rcnt types of information. 
Two important punch codes arc : one 
for punching the 'name card', which gives 
the individual's serial number, name, 
father's or husband's name, household 
number, family relationship, age and sex. 
The other is for the 'analysis card' which 
in addition to serial number, household 
number, age and sex contains all informa­
tion essential for epidemi.ological analysis 
omitting the individual's name, family 
relationship and serial numbers of sputum 
bottles. 
Much of the information in columns 
1-28 is identical for the two cards, being 
data essential for both epidemiological 
analysis and for identification of the 
individual. The two types of cards can 
thus be kept separate and used for separate 
purposes, perhaps sorted and filed in quite 
different sequences. 
PUNCHED CARDS 
From the individual card - The first 
card punched for a person were the 
name card, the fICld-data card and the 
movement card. The field-data card is 
identical with the name card for the first 
28 columns. Thereafter it contains the 
data from boxes 18-22 of the individual 
card (see Fig. 4) punched directly in the 
order in which they appear in the card. 
It will be seen that the field-data card 
contains X-ray roll number, sputum 
bottle numbers and BCG code but no 
results of X-ray or bacteriology. The 
movement card contains, in addition to 
the individual number, the contents of 
boxes 14-17 from the individual card (i.e., 
the identification particulars in the village 
of origin for visitors, settlers and newly 
married women), but is punched only if 
these boxes are filled in; two cards are 
punched if the two lines refer to different 
places or to different persons in the same 
place. 
From the X-ray report - As soon as 
an X-ray film roll was read by both 
readers, an X-ray 'roll master card' was 
punched, with the X-ray roll number, 
identity of the readers, date of reading and 
panchayat number. Further, a card was 
punched, for each abnormal finding 
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directly from the X-ray readers' original 
entries. There may be two X-ray cards 
for a person (if judged abnormal by both 
readers) or one or none. X-ray results 
interpreted as normal were derived from 
thc X-ray roll master card by reproducing 
the identity of the readers into the field­
data card after matching by X-ray roll 
number; if thcrc was a reader but no 
X-ray result, the reading was taken to be 
normal. 
From the laboratory reports-From 
these reports results of microscopy (as 
they became available), culture (punched 
either as soon as they were found positive 
or after eight weeks, if negative) and drug 
sensitivity and identification tests were 
punched. These cards contained bottle 
numbers, but no individual numbers; 
individual numbers arc not supplied to 
the laboratory to ensure that examination 
of the sputum specimen in the laboratory 
is independent of the knowledge of which 
two specimens belonged to the same 
individual. It was therefore necessary to 
prepare a separate set of 'bottle-cards' 
usually two-reproduced from each field­
data card with individual number and 
bottle number. By sorting both these 
bottle-cards and the cards with bacterio­
logical results according to bottle number, 
it is possible to collate corresponding 
cards and transfer the individual number 
to the card with the bacteriological results. 
Analysis card - Finally, the analysis 
card was produced by transferring 
all the information of epidemiologi­
cal interest from the other cards, after 
bringing the information into the required 
format. For instance, the tuberculin 
reactions were pnnched in the field­
data card in the order of 1st test 
and 2nd test (right arm, left arm), which 
is more convenient for the punch clerk. 
The order of PPO-S, PPD-B (which is 
more convenient for statistical analysis) 
was obtained later by logical editing in the 
suitably programmcd tabulator and auto­
matic repunching of the data in the lattcr 
form in the analysis card. 
10. Criteria for defining infection 
and disease 
In epidemiologil:al studies, criteria for 
determining an individual's allergic status, 
or change in status, are best based, not 
on uniform, 'accepted' rules, but on 
studies ofthe pattern of findings in samples 
representative of the population. 
The definition of the allergic status of 
an individual depends on several factors 
such as the allergens used, their dosages, 
variations in reading of reactions and the 
characteristics of the population under 
study. Thus for each population the 
crietria for defming prevalence and inci­
dence of infection will have to be evolved 
by studying the distributions of reactions 
obtained, in that poulation. 
In defining a case of tuberculosis, while 
demonstration of tubercle bacilli (or 
histopathological evidence) is a fairly 
authentic criterion, interpretation of X-ray 
shadows is known to be equivm:al and 
relatively subjective. 
Criterion for defining a reactor 10 
PPD-S - As discussed earlier, it is 
possible that some of the intermediate 
reactions to PPO-S arc nonspecific cross­
reactions to the organism(s) causing 
reactions to PPD_B23'28. The correlation 
of reactions to PPD-S and PPD-B is 
shown in Table 11. The distribution is 
very asymmetrical but scarcely permits 
conel usions concern ing cross-reactions. 
Earlier studiesn had shown that from 
results of dual testing in thosc with 
medium size indurations of 6-11 mm 
TABLE 11 - CoRRELATION BETWEEN SIZE OF REACTION TO PPD-S AND PPD-B FOR AGE-GROUP 1-14 YEARS 
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0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30+ Total 
>-l 
c:: 
t:l 
~ 
tn 
C 
Po 
Po 
.9 
,-.. 
~ 
c; 
00;:: 
u 
~ 
~ 
'­0 
0 
N 
Vi 
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
22 
24 
26 
28 
30+ 
1835 
1042 
163 
26 
10 
3 
5 
11 
7 
4 
1 
5 
1 
-
-
-
2828 
4022 
851 
75 
18 
10 
5 
IS 
11 
17 
14 
4 
7 
1 
-
-
2094 
4473 
1715 
314 
36 
19 
12 
16 
21 
22 
12 
10 
9 
-
-
-
1649 
3259 
1683 
385 
67 
22 
17 
12 
16 
25 
12 
11 
11 
4 
1 
-
1511 
3416 
1494 
497 
90 
42 
21 
35 
47 
33 
22 
23 
26 
6 
4 
-
1545 
3099 
1646 
482 
153 
42 
54 
60 
51 
64 
37 
27 
21 
5 
1 
-
1571 
3074 
1842 
678 
241 
115 
43 
119 
101 
109 
56 
51 
41 
21 
3 
1 
1585 
4002 
3143 
1433 
608 
301 
242 
176 
289 
313 
224 
141 
115 
50 
14 
2 
1154 
2853 
3400 
1968 
926 
551 
360 
456 
391 
622 
510 
365 
270 
113 
30 
5 
624 
1709 
2474 
1733 
889 
601 
441 
586 
665 
749 
847 
548 
429 
193 
58 
14 
208 
558 
818 
660 
400 
305 
245 
330 
426 
625 
405 
501 
523 
235 
72 
18 
106 
219 
363 
291 
238 
169 
114 
222 
213 
299 
285 
174 
338 
210 
97 
17 
21 
86 
150 
180 
114 
86 
67 
107 
118 
136 
182 
217 
213 
259 
86 
24 
6 
18 
20 
27 
18 
16 
17 
14 
30 
55 
39 
59 
88 
37 
57 
22 
1 
6 
7 
4 
3 
2 
2 
2 
2 
15 
9 
9 
25 
24 
4 
9 
1 
1 
1 
-
-
-
-
-
-
1 
1 
2 
1 
2 
4 
2 
16739 
31837 
19770 
8753 
3811 
2284 
1645 
2164 
2388 
3089 
2656 
2147 
2118 
1160 
431 
114 
(J 
c:: 
t"" 
0 
C/l
.... 
C/l 
'" ~ 
<: 
:"t1 
Z 
>-l 
0 
Z 
o-l 
l>d;;: 
t""
-
:s: 
;I>­
0 
:>:' 
;I>­
'" 
TOlal 3113 7881 8753 7174 7267 7287 8066 12638 13974 12560 6329 3355 2046 523 124 16 101106 
...,
 
VI 
36 Indian J. Med. Res. 72 July (Suppl.) 1980 
to 5 TU PPD-S, those infected with 
M. tuberculosis could be clearly separated 
from those not so infected. But in our 
data, the c1assillcation of the study popu­
lation as infected or non-infected on 
the basis of PPD-S and PPD-B testing 
proved impossible4Q • Therefore only the 
results of testing with PPD-S have been 
considered for defining a positive tu ber­
culin reaction. 
Fig. 5 (left half) shows the distributions 
of reactions to PPD-S in different age 
and sex groups in the study population up 
to the age of 34 yr. The distributions 
after the age of 34 yr (not shown) were 
very much similar to the distribution in 
age group 25-34 yr. The frequency of 
large reactions-with a mode at about 
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fo'ig. 5 - Distributions of reactions to PPD-S 
and PPD-B by age and sex 
18 mm-is very small in the youngest 
age groups and gradually increases with 
age up to the age of 25 yr among males 
and up to 35 yr among females and 
remains the same thereafter. The sepa­
ration between the two distributions, i.e" 
the presumably uninfectcd left-hand distri­
bution and t.he presumably infected right­
hand distribution, is far from sharp. 
Even for the age groups 1-4 and 5-9 yr 
there is much overlapping bet.ween the 
two classes. However the 'antimode', 
i.e., the dip between the two distributions, 
is mostly around 12 mm, which therefore 
is taken as a limit defining 'reactors' to 
PPD-S on tbe expectation that with this 
limit 'false positives' and 'false negatives" 
will tend to cancel each other. 
It may be noted that among more 
than 1000 patients having at least two 
positive culturcs of M. tuberculosis each, 
only 1.4 per cent, and among nearly 
800 patients having one positive culture 
of M. tuberculosis each, only 3.6 per cent 
had reactions to PPD-S smaller than 
12 mm. This implies that the test thus 
defined is highly sensitive. 
However, for studying the protective 
effect of BeG vaccination among the non­
infected, only persons reacting with 
0-7 mm to PPD-S have been considered 
as 'definitely not infectcd'. 
Criterion for defining a reactor to 
PPD-B - Fig. 5 (right half) shows the 
distribution of reactions to PPD-B in 
different age and sex groups, also up to 
the age of 34 yr. The distributions after 
the age of 34 yr (not shown) were very 
much similar to the distribution in age 
group 25-34 yr. Even among children 
aged below 5 years, there is no point of 
separation between subjects who may be 
classified as reactors and those who may 
be classified as non-reactors. Among 
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those aged 15 yr or more the distributions 
of reactions are unimodal and may be 
regarded as consisting of reactors only. 
Such reactors would seem to have about 
10 rnm or larger reactions to PPD-B. Also 
the skewness among the three younger 
age grou ps is largely to the left of 
10 nun and thus a reaction of 10 mm or 
more to PPD-B has been adopted as 
the criterion for derining a reactor to 
PPD-B. 
Criteria for defining an X-ray case of 
tuberculo.l'is-To obtain from our material 
an idea of the inter-reader variation, the 
correlation of the X-ray readings of two 
readers, who had read the large$t numbers 
of photofluorograms during intake was 
studied. For tbe three most severe cate­
gories of X-ray readings, Le., 7, 8 or 9, 
indicating evidence of a definite or doubt­
ful cavity, reader I classified 160 in the 
above categories while reader II, 294. 
However, the readers were in agreement in 
only 130, or 40 per cent of the '524 picked 
out by either. If code 6, oft..:n indicating 
pulmonary infiltration, was added the 
agreement was of the order of 44 per cent. 
Correlation of the readings of the 
same two readers by the alphabet code, 
i.e., codes C or D indicating possible or 
probable tuberculous aetiology, was also 
studied. Reader I classified 2913 accord­
ing to the ahove two codes and reader Ir, 
2748, but they agreed in only 1797 cases, 
or 47 per cent of the 3864 persons classified 
as C or D by ei ther reader. Of the 2913 
persons so classified by reader I, 21 per 
cent and, of the 2748 by reader II, 22 per 
cent yielded cultures positive for 
M. tuberculosis. The low agreement bet­
ween the two readers and the relatively low 
bacteriological confirmation suggest that 
.the evaluation of X-rays in a survey, 
especially based on a single photolluoro­
gram appears to be unsatisfactory for 
arrivhlg at a definition of an X-ray case 
of pulmonary tuberculosis. 
In view of these d ifl'erenccs in the X-ray 
readings betwecn the readers no absolute 
criterion for definition of a 'case' of 
pulmonary tnberculosis based only on 
X-ray is available. ]n this report, persons 
(abacillary) for whom photofluorograms 
were classified, according to the alphabet 
code, as C or D by both readers arc 
refcrrcd to as X-ray cases. Photoli uoro­
grams classilled as belonging to category 
C or D by one of the readers only were 
submitted to a third reader. Persons for 
whom the photofluorograms were then 
c1assitled as C or D by the third reader 
are also considered as X-ray cases. 
CRITERIA FOR DEFINING A RACILLARY CASU 
OF TUUERCULOSIS 
Cases positive on smear only-It will 
be recalled that for each individual e1igi­
blc for sputum examination, attempts were 
made to collect two samples of sputum 
which were examined by direct smear and 
eulture techniques. 
Table 12 presents, for the 260R cases 
positive on smear and/or culture at intake, 
correlation of the results of direct smear 
and culturc in terms of the numher of acid 
fast ba.eilli (AFR) on direct smear and the 
number of colonics on culture. Of the 
two sputum specimens collected from 
each individual, the specimen that 
showed the highest number of bacilli on 
smear and the specimerl that showed 
the highest colony count on culture 
are considered for the correlation. 
It will be observed that out of 2608 in­
dividuals, 567 (22 per cent) were positive 
on smear only, while 869 (33 per cent) 
were positive on culture only. Of the 
567 persons positive on smear but negative 
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TAIlLE 12 - CORRELATION DETWEEN RESULTS OF DIRECT SMEAR AND CULTURE FOR BACILLARY CASES 
DIAGNOSED AT INTAKE 
No of acid fast bacilli in smear
 
No of
 Total 
colonies on 0 1-3 4-5 6-11 12-24 25-99 +1++ +++

culture
 
0 430 55 36 16 3 26 567 
1-3 445 16 3 2 I 2 6 476 
4-5 80 4 3 2 I 4 94 
6-9 58 5 2 5 1 1 6 n 
10-24 130 16 3 10 2 2 20 184 
25-49 59 8 1 6 7 2 18 101 
...L 60 6 7 20 11 6 85I 195 
34 16 6++ 20 18 18 398 32 542 
3 1 31++ 6 218 140 371 
Total 869 501 81 104 57 40 781 175 2608 
VMB'" 116 23 13 8 4 7 172 
·Unclassitied mycobacteria, irrespective of number of colonies; Most of these cases were culture 
negative on one of the two specimens 
on culture, 430 (76 per cent) had only 
1-3 bacilli while another 55 (10 per cent) 
had 4 bacilli. 
Whether the 567 cascs, positive 011 
smear only, can be considered as bacillary 
cases is doubtful. The reproducibility 
was poor : only 6 per ccnt among males 
and 4 per cent among females showed 
bacilli ou both smears examined. The 
X-ray confirmation (C or D by two 
readers) in such pcrsons was also only 
13 per cent. The problem of smear 
positive and culture negative cases has 
been examined by Raj Narain and associ­
ates45, in another survey conducted not 
far from the area of the study, but using 
the same techniques. In that study also 
the findings were similar and it was sugges­
ted that cases showing only 1-3 bacilli 
on smear and negative on culture should 
not be considered as bacillary cases. For 
these reasons, smear positive and culture 
negative cases have becn presented in the 
material after excluding all cases who had 
shown only 1-3 bacilli on the whole smear. 
The above conclusions are in no way 
affected even when the result of the speci­
men giving the highest number of 
colonies on culture and the corresponding 
result of smear examination of the same 
specimen was correclated. 
Cases positive on culture : It will be 
appreciated that in this report, culture 
positive cases mean those in whom the 
culture growths from sputum specimens 
have been classified as M. tuberculosis 
bascd on morphological characteristics 
of the colonies, niacin test and other 
identification tests (see Table 10). 
All culture positive cases do not 
present unifonn charactcristics in terms 
of reproducibility of the culture result, 
confirmation by direct smear or by radio­
logy. Thus several categories of culture 
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positive cases can be identified : those 
posltlve on culture on two specimens 
(sputum samples) and those positive on 
culture on only one specimen when more 
than one specimen is examined; those 
positive on both culture and smear and 
th05e positive on cuILure only. 
Presented below are some of the 
characteristics of thc culture positive 
cases in relation to the results of smear 
examination. Of the total 2041 culture 
positive cases diagnosed at intake 1852 
cases for whom two culturcs and two 
smears have been examined are included : 
CuI. CuI. 
pos. pos. 
Smear Smear 
pos. neg. 
Total cases 1097 755 
CuI. pas. on 2 specimens 968 235 
CuI. pos. on 1 specimen 129 520 
C or D by 2 readers 989 492 
It will be observed that among the J097 
cases that were positive on both culture 
and smear 968 (88 per cent) were positive 
on culture of two specimens while the 
corresponding proportion for those posi­
tive on culture only was 31 per cent i.e., 
235 out of 755. Further, cases positive 
on culture and smear had X-ray confir­
mation in 989 (90 per cent) while those 
positivc on culture only had X-ray con­
firmation in only 492 (65 per cent) of the 
755 cascs. Reproducibility of culture 
results as well as confmnation by other 
techniques were distinctly higher among 
eases positive on both culture and smear 
than among cases positive on culture 
only. 
Another aspect in which the culture 
positive cases could be examined is by 
comparing the cases positive on one 
culture only with those positive on two 
Ctllturcs in terms of number of colonies 
observed on culture growth. Table 13 
presents the distribution by number of 
colonies of 2041 cases, culture positive for 
M. tuberculosis at intake, scparately for 
those positive on one culture only and 
for those positive on two cultures, and 
separately for three age groups. For 
persons with two positive cultures the one 
showing higher number of colonies is 
considered. 
It will be observed that in the age group 
10-24 yr, of the 65 eases positive on one 
culture only, 45 (69 per eent) had less 
than 6 colonies, whereas the corresponding 
proportion was 8 out of 86 (9 per cent) 
among those positive on two cultures. 
Among cases positive on one culture only 
and having less than 6 colonies, 26 (58 
per cent) out of 45 had only one colony 
on the culture. The trend was vcry similar 
in a~l age groups. 
CASES OF TUBERCULOSIS 
The prcsentation above is not an 
exhaustive examination of the charac­
teristics of cases of tuberculosis nor an 
attempt to evolve a definition of a case 
of pulmonary tuberculosis. There is 
little doubt that cases positive on two (or 
more) cultures can be considered as true 
cases of pulmonary tuberculosis. On 
the other hand eases positive on one cul­
ture onJy have characteristics that are 
markedly c.IilTcrent from thosc positive on 
two or more cultures. It is quite likely 
that most of these cases are true cases of 
pulmonary tuberculosis being the so­
called 'early cases', but some 'false 
cases' (mislabeled in the field or contami.­
nated in the laboratory) would also be 
----
.t>­
o 
TABLE 13 - DISTRIBUTION BY NUMBER OF COLO:-<IES ON" CULTURE AND BY AGE OF PERSONS CULTURE POSITIVE FOR AI. tuberculosis AT IKTAKE,
 
SEPARATELY FOR PERSONS POSITIVE ON 01'E CULTURE OlSLY AND THOSE POSmVE ON Two Ct:LTURES
 
~ Age group (in yr) eo: § 
10-24 25-44 45- Total ~ 
No of +ve on +ve on +Ve on ·-j·ve on +ve on +ve on +Ve on +ve on ~ 
colonies 1 culture 2 cultures 1 culture 2 cultures 1 culture 2 cultures I culture 1 cultures '1> F>-­
~ o,c: 0/ 0/ r-;,No % No % No % No % No % No ,0 No /0 No /0 ;-> 
-:J 
N 
01 26 40.0 1 1.2 107 32.7 6 I.I 141 31.6 16 2.9 274 32.7 23 1.9 ? 
02 9 13.8 3 3.5 37 11.3 10 1.8 51 11.4 10 1.8 97 11.6 23 1.9 ~ 
03 4 6.2 2 2.3 19 5.8 3 0.5 23 5.2 8 1.4 46 5.5 13 I.I 
V:l04 4 6.2 2 2.3 14 4.3 3 0.5 26 5.8 8 1.4 44 5.3 13 I.l 
.§
05 2 3.1 - - 9 2.8 2 0.4 19 4.3 5 0.9 30 3.6 7 0.6 "5 
"­06-24 8 12.3 6 7.0 55 16.8 50 9.0 81 ]8.2 62 1I.l 144 17.2 118 9.8 ~ 
25-99 10 15.4 11 12.8 38 11.6 99 17.8 50 11.2 88 15.7 98 11.7 198 16.5 
'C> 100 2 3.1 41 47.7 32 9.8 217 39.0 40 9.0 210 37.5 74 8.8 468 38.9 00 
Confluent growth - - 20 23.3 16 4.9 167 30.0 15 3.4 153 27.3 31 3.7 340 28.3 0 
Total 65 100.0 86 100.0 327 100.0 557 100.0 446 100.0 560 100.0 838 100.0 1203 100.0 
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'included here. All cases were put on 
treatment with anti-tubercular drugs and 
thus the study of the fate of these cases 
would not provide reliable evidence on 
whether some cases in either group were 
false cases and as sUl:h could be excluded 
for obtaining estimates of ditTerent epi­
demiological indices. In view of the above 
considerations, four catl:gories of cases 
are presented separately in the material 
dealing with prevalence of diseases. (i) 
,cases positive 011 two cultures, (ii) l:uses 
positive on one culture only (iii) cases 
positive on smear only, excluding those 
showing 1-3 AFB on the entire smear and 
(iv) abaeilIary X-ray positive cases (C or 
D by two readers). 
11. Study population 
During intake, the entire popualtion in 
the study area was registered, but only 
the d('jure population has been considered 
for this report. A dejure population ex­
cludes visitors but includes permanent 
residents who wcre temporarily away. 
The registered population, the dejure 
population and among the dejure popula­
tion, numbers tuberculin tested, 'vaccina­
ted', X-rayed and sputum examined, 
in different age groups, are shown in 
Tables 14 and 15 for males and females 
respectively. 
The age pyramid both for the total 
registered and the resident (dejure) popu­
lation is shown in Fig. 6. It is observed 
TADLE 14 -- POPULATION REGISTERED ANn COVERAGES OBTAINED FOR VARIOUS EXAMINATIONS DY 
AGE IN MALES 
Age Population Dejure No No No Sputum Examination 
group registered papula- vacci- test-read X-rayed 
lalion nated No Doth Only one 
eligible specimens specimen 
examined examined 
<1M 865 76t not eligible 
1-11 M 4605 4270 2301 not eligible 
1-4 y 19469 Hl521 14135 14148 not eligible 
5-9 y 23342 22701 19476 19340 not eligible 
10-14 Y 23152 22402 19724 19352 20027 965 868 31 
15-19 Y 15254 14721 11923 11432 12115 673 578 34 
20-24 Y 14651 13984 11012 10286 11236 851 680 77 
25-29 Y 14965 14357 10848 10145 11163 1129 952 69 
30-34 Y 13419 12988 9511 8987 9894 12110 lOll8 69 
35-39 Y 12253 11997 8859 8432 9204 1467 ]224 97 
40-44 Y 9908 9708 7122 6856 7464 1438 1218 115 
45-49 Y 9384 9233 6968 6743 7348 1639 1434 80 
50-54 Y 7307 7181 5400 5232 5738 1465 1266 76 
55-59 Y 5868 5761 4401 4303 4684 1343 1172 70 
60-64 Y 4599 4501 3379 J298 3638 1107 974 50 
65-69 Y 3007 2939 2209 2203 2466 833 732 45 
70 I- Y 30116 2993 1768 1885 2275 812 708 50 
Total 185134 179018 139036 132642 107252 15002 12894 833 
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TABLE 15 - POPULt\TlON REGIST~RED AND COVERM,ES OOTt\lNED fOR VAIUOUS EXAMINt\TlONS DY 
AGE IN FEMt\LES 
Age Population D':iure No No No Sputum Examination 
group regis- popula- vacci- test- X-rayed 
tered tion !lated read No Doth Only one 
eligible specimens specimen 
examined examined 
< 1 M 941 820 not eligible 
1-11 M 4789 4471 2459 not eligible 
1-4 y 19091 18174 13880 13899 not eligible 
5-9 y 23333 22592 19157 19020 not eligible 
10-14 Y 20440 19781 17568 17456 17832 1070 990 23 
15-19 Y 14016 12879 10292 10239 10713 547 480 17 
20-24 Y 17569 15880 10811 10894 12321 677 611 24 
25-29 Y 16238 15372 11370 11550 12966 ~82 811 2l 
30-34 Y 12761 12363 9568 9702 10604 873 803 30 
35-39 Y 11491 11235 9149 9200 9807 951 867 29· 
40-44 Y 9549 9344 7559 7514 7973 930 853 32 
45-49 Y 8737 8487 6913 6811 7263 1073 978 33 
SO-54 Y 7277 6999 5375 5289 5687 881 789 39 
55-59 Y 5698 5417 4169 4163 4471 858 752 43 
60-64 Y 4189 3945 2626 2664 2993 642 568 31 
65·69 Y 2704 2553 1641 1721 1976 45~ 388 30 
70-1- Y 2668 2523 882 1078 1442 424 359 33 
Total 181491 172835 133419 13[200 106048 10266 9249 3~5 
o '0 
Fig. 6 - Total registered population and resident (de jure) population by age and sex_ 
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that there are much fewer persons in the 
age group 15-19 yr than in the younger 
age groups. This may be duc to a bias 
in age estimation, or among males due to 
emigration in search of employmcnt or 
for education. 
During intakc a total of 366, 625 
persons were registercd. The dejure 
population consisted of 351, 853 persons 
(179 01 S males and 172, 835 females). 
Of those eligible, 77.8 per cent wcre 
'vaccinated'; 77.3 per cent tubercul in teskd 
and read, 82,2 per eent X-rayed and 
92.5 per cent sputum examined. Of those 
X-rayed, 11.8 per cent were eligible for 
sputum examination while 11.0 per cent 
had sputum examined by one or both 
specimens. 9680 (or 3.3 per cent of those 
examined for scars) persons who had a 
scar suggestive of previous BCG vacci.na­
tion elsewhere have; been excluded from 
analysis. 
Prevalence of reactors to tuberculin 
(PPD-S)-Considering persons with 12 
mm and bigger reactions to PPD-S, 
irrespective of the siLe of reaction to 
PPD-B, as infected with M. tuberculosis, 
the prevalence of infection in the study 
population by age and sex is ShOWll in 
Table 16, and Fig. 7. The overall infection 
prevalence was 50 pCI' cent; 54 per cent 
among males and 46 per cent among 
females. 
The prevalence of infection rose rapidly 
from the youngest age group lip to about 
25 yr among males and 35 yr among 
females and then almost levelled off. 
At those ages, over 80 per cent of males 
and 70 per eent of females were infected. 
The infection prevalences were lower 
among females than among males for age 
groups beyond 15 yr. 
'Sex difference' in reactions to PPD-S-­
Distribntions of reactions to PPD-S for 
TABLE 16 - NUMIIER AND PERCENTAGE OF REACTORS (;;il> 12 mm) TO PPD-S BY AGE ANI) SEX 
Males Females 
Age 
group No of No % No No of % 
(yr) test-read reaCTOrs test-read reactors 
1-4 13937 681 4.9 13722 726 5.3 
5-9 19091 2892 15.1 111788 2747 14.6 
10-14 18789 5993 31.9 17049 4904 28.8 
15-19 10655 5669 53.2 9720 4128 42.5 
20-24 9538 61157 71.9 102116 5546 53.9 
25-29 9632 7719 1l0.1 11136 692! 62. t 
30-34 8707 7288 83.7 9425 6241 66.2 
35-39 8266 7040 85.2 11980 6297 70.1 
40-44 6760 5769 85.3 7356 5392 73.3 
45-49 6657 5752 1l6.4 6687 4894 73.2 
50-54 5195 4380 84.3 5215 31175 74.3 
55-59 4278 3550 no 4128 2983 72.3 
60-64 32110 2692 82.1 2654 1917 72.2 
65-69 2192 1742 79.5 nIl 1242 72.6 
70+ 1877 1510 80.4 1074 786 73.2 
Tot.al 128854 69534 54.0 127931 58599 45.1l 
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Fig. 7 ­ Prevalence of infection (12 mm or more lo PPD-S) by agc and ~ex 
the two sexcs in Fig. 5, left half, show be observed that even in age group 1-4 yr 
practically no difference up to thc agc of the prevalence was as high as 34.4 per 
15 yr. After that age there is a remarkably cent and rose steeply so that by about 
constant diJTcrcnce. Frequency of small 15 yr, almost everybody was a reactor. 
reactions (say, below 10 mm) is higher Further, unlike for PPD-S, there were no 
among females. Frequency, of large difTerences in the prevalences between 
reactions (say, between 10 and 22 mm ) males and females. 
is higher among males and of reactions The absence of any difference in the 
larger in size than about 22 mm is again prevalences hetwcen the two sexes suggest 
higher among females. that this massive sensitisation is caused by 
This phenomenon was also reported environmental mycohacteria, which how­
earlieri4'75. WHO Tuberculosis Research ever, rarely cause lung disease in lUan in 
Offil:e 7G reported the same phenomenon this population. 
and stated that reactions in women Also, because of this massive scnsiti­
were larger and varied more in size than sation, analysis of incidence of disease 
in men. The same phenomenon can abo among individuals without nonspecific 
be seen, to a lesser dcgree, for PPD-B sensitivity has not been feasible. 
reactions. Its sign ificance is not known. Prevalence of bacillary cases of tuber­
Prevalence of reactors to PPD-B­ culosis - Tables 18 and 19 (males antI 
Fig. 5, right half, shows the distributions females respectively) show the distribution 
of reactions to PPD-B as frequency poly­ by age and the corresponding prevalences 
gons, in fIve age groups up to 35 yr. As for three categories of bacillary cases, 
explained in Chapter 10, considering per­ i.e., cases positive on culture on two 
sons reacting with 10 mm and above to specimens, cases positive on culture on 
PPD-B as reactors the prevalences by age one specimen only, and cases positivc on 
and sex are shown in Table 17. It will direct smear only (with more than three 
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TABLE 17 - NUMBER ANlJ PIoRCENTAGE OF REACI'ORS (~ 10 mm) TO PPD-B BY AGE AND SEX 
Males Females 
Age 
group No No of % No No Qf % 
(yr) test-read reactors test-read reactors 
1-4 13846 4708 34.0 13632 4746 34.8 
5-9 19065 12750 66.9 18754 12684 67.6 
10-14 18772 16869 89.9 17037 15161 89.0 
15-19 10651 10358 97.2 9714 9210 94.8 
20-24 9535 9408 98.7 10285 9911 96.4 
25-29 9629 9518 98.8 11128 10842 97.4 
30-34 8704 8641 99.3 9415 9190 97.6 
35-39 8259 8185 99.1 8964 8772 97.9 
40-44 6754 6677 98.9 7344 7183 97.8 
45-49 6647 6553 98.6 6680 6511 97.5 
50-54 5189 5093 98.1 5199 5035 96.8 
55-59 4272 4174 97.7 4122 3964 96.2 
60-64 3274 3172 96.9 2642 2522 95.5 
65-69 2188 2122 97.0 1702 1618 95.1 
70+ 1881 1806 96.0 1075 1007 93.7 
Tolal 128666 110034 85.5 127693 108356 84.9 
bacilli on the entire smear). In all, 2041 
culture positive cases were detected in a 
population of 206,609 persons X-rayed 
giving a prcvalence (adjusted) of 1068 
per 100,000; 1704 among males and 439 
among females. The prevalence of cases 
culture positive on two specimens was 
664 pcr 100,000 (I 106 among males and 
234 among females) and that of cases 
culture positive on one specimen only was 
404 per 100,000 (598 among males and 
205 among females). The prevalence of 
cases culture negative but smear positive 
(>3 AFB) was 101 per 100,000; 139 
among males and 63 among females. 
For all categories of cases, prevalence of 
discase is lower among fcmales than 
among males and increases as age 
advances in both sexes as also seen 
from Fig. 8. However, as the definition 
of a case becomes less rigorous the diffe­
renee in prevalence between males and 
females also reduces. 
It may be of interest [or purposes of 
comparison with other prevalence surveys 
to stndy Ihe prevalcnce of bacillary cases 
of tuberculosis, where cases are classifred 
taking the Tesults of both smear and cul­
ture into consideration. Table 20 pre­
sents the number of two categories of 
cases, i.e., those that are bolh smear and 
culture positive and those that are positive 
on culture only, dislributed by age and 
sex. It will be observed, from comparison 
of data in Tables 18, 19 and 20, that the 
prevalence of culture posilive and smear 
positive cases was similar to the prevalence 
as seen for cases positive on two cultures 
and the prevalence of cases culture posi­
tive and smear negative was similar to the 
prevalence as obtained for those positive 
on one culture. 
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TAnlI: 18 -- PRl:VAUl\:CE OF BACILLARY CASI:S 0:-1 CUl.TURE AND SMEAR, nv AG[, MAI.~.s 
Age No Bacteriolugiea I Culture po~ili\'~ Culture positivc Smear positive 
group No eligible for spc.:imcn on two nn nne (> 3 i\FB), 
(yr) X-rayed bact. exam. examincd specimens specimen only l"lIltur" negative 
twice ont."c No per No per No per 
100,000 100.000 100,000 
10-14 19437 939 !(46 2H 2 II 5 28 <) 50 
15-19 11272 620 533 32 15 155 4 30 5 49 
20-24 10408 781 (,28 (.9 44 526 31 lin 9 97 
25-29 10607 10lQ 912 66 86 962 35 300 15 156 
30-34 9588 1239 1050 68 110 1154 50 495 10 116 
35-39 9017 ]-n6 1201 96 133 1764 84 <)00 8 98 
40-44 7~~57 1417 1200 84 1J4 J830 70 930 14 210 
45-49 7253 1617 1412 80 127 2005 63 834 18 269 
50-54 5695 1455 1259 75 ]13 2293 79 1384 7 134 
55-59 4657 1333 1164 70 96 2361 (,6 1397 I[ 255 
60-64 3617 1102 970 50 63 1979 54 15[6 12 358 
65-69 2455 827 728 45 47 2175 43 1747 7 305 
70+ 2266 812 708 50 36 HU2 47 2102 7 331 
Total 103629 14660 12611 813 986 1106 631 598 132 139 
The r:ltes are based on the assumption that persons eli~ible for bacteriological examination, 
but not examined, have the same rates as those examined. Thus if 
x = no. of persons X-rayed; e = persons eligihle for bad. exam.; i - persons hact. exam. 
onee; ii = persons bact. exam. twice; p = persons cult.ure positive once; pp = persons culture 
positive twice; 
then the rate of persons culture positive twice wi11 be 
pp e 
ii x 
and the rate of persons being culture positive either once or twice 
p ! pp e 
-
i-c·li x 
so that the rate of persons culture positive once only is the laller minus the runner 
1l may be recalled that the overall the population had a high prevalence of 
coverage for X-ray examination was 82.2 bacteriologically proved cases of tuber­
per cent and for sputum examination culosis, as compared to findings [rom simi­
92.5 per cent. To what extent the non­ lar surveys conducted in rural arcas in 
response groups have alTected the preva­ India,,2';4'77. 
lence is not known. Even in the hypothe­ Prevalence of X-ray cases - Table 21 
tical case t.hat tbe non-response groups and Fig. 8 present the number or abaci­
had a lower prevalence, it can be said that lIary X-ray ca:"es diagnosed and the 
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TAnu-. 19 .... PRFVAU·.NCI: OF BACIl.LARY C.\SES ON CULTURE ANI> SMEAR BY AGi', FEMAU"~ 
No Bacteriological Culture positive Cullure positive Smear positive 
Age No dgiblc specimen on {\Vll 011 one (>.1 AI-B), 
group X-r,lycd for bact. examined specimens specimen only eultur n gativc 
(yr) exanl. 
!wi<:<; OIKe 0 per Nil per Nll per 
!OO,OOO 100,000 100,000 
10-14 17412 1046 %R 23 3 19 3 J7 6 36 
15-19 10/70 514 451 J6 3 34 5 53 3 32 
20-24 11654 642 579 23 19 181 17 148 2 18 
25-29 ]2505 843 772 21 24 210 16 130 2 17 
30-34 10300 843 774 30 27 286 22 2J3 7 71 
35-39 9576 928 846 29 31 355 23 243 8 89 
40·44 7805 9iS 840 32 32 447 27 346 4 54 
45-49 7134 1053 960 33 30 46J ]0 431 8 J 19 
50-54 5609 874 78l 39 15 299 22 402 4 76 
55-59 4434 851 745 4] 14 361 15 345 (, 14·(, 
60-64 2981 641 567 31 II 417 14 482 3 108 
65-69 1964 457 387 30 4 241 8 429 5 279 
70+ 1436 423 358 33 4 329 5 349 3 226 
Total 102980 10030 9030 383 217 234 207 205 61 63 
Calculation of rates same as shown in Table .0I"
corresponding prcvulcnces among the 
X-rayed population. The overall prevalen­
ce for both sexes was 1429 per 100,000; 
1886 among males and 978 among 
females. Though there is an increase in 
prevalence as age increases, as seen also 
for the bacillary cases, the trend alone may 
not justify that thesc arc all true cases of 
tuberculosis. There is a relatively larger 
number of X-ray cases in the very young 
(10-14 )'1') and the very old (65 yr and 
more) compared to the bacillary cases 
in these age groups. The higher preva­
lences among young children may be due 
to reading of their X-rays as hilar adeni­
tis and in whom the sputum specimens 
in almost all instances were abaciJlary. 
Among the old it was possibly due to the 
elassiflcation of healed tuberculous lesions 
seen on X-ray, as 'active'. On the other 
hand, it is also likely that a proportion of 
these shadows are simply !1onspceilic in 
nature, but radiologically classificd as 
C or D. 
12. Follow-up methodology 
Follow-up of study population to dia­
gnose new cases of tuberculosis that have 
developed after intake comprises three 
activities: resurvey, selective casclinding 
and passive cascfinding. Samples of the 
population were also followed up at 
different intervals after intuke for eliciting 
the stalus of tuberculin allergy (post­
vaccination allergy) after 'vaccinution'. 
The methods adoptcd are described below. 
Techniques followed for X-ray and 
sputum examinations during follow-up 
were the same as those adopled at the time 
of intake. 
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Fig. 8 - Prevalence of disease for 4 categories 
of cases, by age and sex. (a) cases culture + ve 
on 2; (b) culture + ve on one specimen only; 
(c)	 culture - ve, smear -I- vc (>3AFB) ; (d) 
Abacillary X-ray cases (C or D by two) 
Resurvey : The resurvey aetlvlty is 
run continuously covering the study popu­
lation systematically cvry 2~ yr. Thus 
the interval between two consecutive 
surveys for each village would be almost 
exactly 2! yr. 
As from the first resurvey round, eligi­
bility for X-ray examination was extended 
down to persons aged 5 yr and above, so 
that at the 5 yr follow-up, (i.e., second 
resurvey) the cohort from intake was 
examined irrespective of age. 
The resurvey activity comprises of 
updating census through registration of 
new entrants in the study population (new 
born, settlers, persons missed in the 
previous round, and visitors), X-ray 
examination, sputum collection, and 
finger-printing at 
collection but no 
BeG vaccination. 
these examinations 
for intake. 
the time of sputum 
tuberculin testing or 
The procedures for 
are the same as 
Half-way through the second resurvey 
the eligibility criteria for examinations in 
the resurvey had to be changed for reasons 
of economy. It had also become clear 
at that time that the main target group of 
the trial, i.e., persons with smaller tuber­
culin reactions at intake, yielded a 
very small proportion of all new cases. 
Therefore efforts were concentrated on this 
group comprising persons with a reac­
tion size of 0-15 mm to PPD-S at intake 
and in addition, irrespective of the size of 
reaction to PPD-S, those falling into a 
'high risk' group (with suspect X-ray 
shadows or smear positive though culture 
negative in the previous examination). 
However, in a random sample consisting 
of one-third of all panchayats included in 
the study. all individuals aged 5 yr and 
above were examined according to the 
criteria adopted for the first resurvey. 
Selective case-jinding - At intervals of 
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7~ mo. or later (after second resurvey) 
10 mo (i.e.• three or two times hetween 
two surveys) every village was visited and 
any person with a suspect X-ray shadow 
or a bsent for X-ray at the previous 
examination was offered an X-ray exami­
IHltion. Also, each household was in­
formed that persons suO"cring from 
chronic cougb or ebest pain should report 
for an X-ray ex.amination. At the exami­
nat ion centre, persons were identified 
using population registers (see Chapter 
13 and each person X-rayed. Later, 
from persons whose photofluorograms 
showed any abnormality samples of spu­
tllm were collected. For pcrsons classifted 
as bacteriological suspccts (i.e.. smear 
positive but culture negative) at the pre­
violls examination sputum was collected 
irrespective of the results of X-ray exami­
nation. At the time of sputum collection 
a fresh set of finger prints were obtained 
as descrihed earlier. 
Passil'e case-finding - A tuberculosis 
clinic was established by the project in 
the premises of the Government Hospital 
in Trivellorc with a static X-ray unit and 
sputum collection facilities. Any person 
reporting there with symptoms suggestive 
of tuberculosis, whether referred by the 
hospital's out-patient clinic or by a pri­
vate practitioner. or self referred, could be 
examined on any morning. In addition, 
the tcn rural general periphcral health 
institutions in the study arca were visitcd 
along with an X-ray unit every two to 
fOllr weeks, for examination of sympto­
mati.es referred by the medical officers of 
those institutions or private practitioners 
in the area. 
Tn this activitye<leh symptomatic was 
carefully identified II ing population regis­
ters, an X-ray was takcn and a spot­
specimen of sputum obtained at the same 
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time. The laboratory was requested to 
process only those sputum specimens 
collected froIn pcrSOlls whose X-ray pic­
tures showed any ahnormality. Efforts 
were also made to obtain a second sputum 
specimen from persons with abnormalities 
on X-ray. The sputUIn specimens l:ollect­
ted from others were discartlcd. At the 
time of each sputum collection finger 
prints were taken. 
[n time, this service became well known 
and popular. and accounted for abollt 
one-thirtl of the total cascs found. 
Addirional samples oj" spurum --- Irres­
pective of the method of follow-up, efforts 
were made to ohtain all additional speci­
men of sputum whenever a specimen was 
reported as contaminated by the labora­
tory. During visits to the villages for 
this purpose, elTorts were also made to 
collect additional samples of sputum from 
those whose smears were positive (to 
guard against the possihility of the COtTeS­
ponding cultures gctting conlaminatcd) 
and from whom only one positive culture 
result was obtained. On this occasion 
also finger-prints wcre obtained as part 
of identiflcation of the ind ividual. 
Repeat tuberculin tests - Repeat tuber­
culin tests were carried out in random 
samples of population groups at 2~ mo. 
2~ yr and 4 yr after intake. (As described 
in Chapter 5, most of Trivellore town was 
not retcsted according to this design, i.e., 
testing was done only at 2~ 1110). The 
retests were carried out mainly for the 
evaluation of tuberculin allergy at different 
intervals after vaccination. For each 
retesting a separate sample of popula­
tion was selected so that no individual was 
tested more than tVliee i.e., once at 
intake and again at the time selected for 
retesting. 
All retests were carried out with 3 
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IU or PPD-S injected at a different site 
than used for the flrst two tests at intake. 
Retesting {If 2! 1710 - - First rctesting 
was carried out n mo after the vaccina­
tion. Thc exact average interval was 
75 days, the range bcing 62 to 99 days. 
A 10 per cent random sample of the popu­
lation was selected for measuring the size 
of the vaccination lesion and record ing 
its nature and of this, one-fifth (2 p~r cent 
sample) for assessing the size of post­
vaccination allergy_ The mcthod of 
sampling is already described under 
Chapter 5. 
Retesting at 2! yr - For the 2t yr 
retesting, a 5 per cent random sample of 
thc population was drawn. The sampling 
methodology has already been described 
in Chapter 5. 
Retesting at 4 yr - A tcn per cent 
sampic of thc total population had been 
selected for lesion-reading at 2-} rna 
and another 5 per ccnt sample for retesting 
at 2'~ yr_ The remaining HS per cent of 
the total population was included for 
retesting at 4 yr after intake. For this 
retesting, all individuals agcd up to 30 
yr at intake and who had been 'vaccinated' 
and children born after intake, were 
eligible. 
TREATMENT OF CASES 
Cases diagnosed at intake or in any 
of the foIlmv-up activities were put on 
domiciliary treatment with anti-tuber­
cular drugs. Treatment was organised 
by the clinic run hy the project or under 
the supervision of the clinic in anyone of 
the ten general health institutions in the 
study area. 
13. Rec l"d Iinka~e at follow-up 
Machinery - As the data for each 
person from more than one round occu­
pied several punched cards, the tabulator 
was found inadequ<.lte and towards the 
end of intake it was replaced by a computer 
(IBM I401-H). 
Records, punched card~ (lml pl/l1rh 
code'S -- Except for dclails mentioned in 
the next three paragraphs, records and 
punch codes are virtually the same as 
used during intake, 
For eaeh resurvey or round of selec­
tive caseilnding, the computer prints 
out by means of the punched name cards 
from the previous survey, new individual 
cards approximately of the form shown in 
Fig_ 4, with all identification particulars 
but omitting details of previous examina­
tions. New information for each individual 
(change in eenSllS stutus, household num­
ber or relationship, and X-ray roll number 
of the X-ray taken in that round) is entered 
in these cards in the field; the cards are 
returned daily and the information imme­
diately punched. 
l:.Jigibifity for sputum collection - The 
punched cards with the information from 
the individual cards and the punched cards 
with the concurrent X-ray readings are 
passcd through the computer on a daily 
basis and the computer will for each person 
without X-ray abnormality, or ineligible 
for X-ray, punch an up-dated name card 
and an analysis l:ard for the current 
round. For persons eligible for sputum 
collection the machine prints out an 
individual card with name and census 
status of the person and a rcqucst for 
collection. In the field, the serial numbers 
of the sputum containers used are entered 
in this card, and the numhers are punehed 
and later collated with the laboratory 
results as described for intake (Chapter 9)_ 
Additional examination lind diagnosis­
All carus for any person for whom sputum 
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collection has been requested are trans­
ferred to another computer program, run 
on a weekly basis, and kept there till all 
examinations for the current round have 
been completed, by which time the ma­
chine punches the updated name card and 
current analysis card. To the card deck 
for this weekly program are added exami­
nation results as they become available, 
especially bacteriological results. In each 
weekly run, the machinc reads in all 
available information for one person at 
a time and determines whether any action 
is indicated. Possible actions of the 
machine are : request to the field for 
collection of a third sputum specimen 
(e.g., if a specimen is reported from the 
laboratory as being contaminated); request 
[or umpire reading of X-ray (e.g., in case 
of any positive bacteriological finding but 
with X-ray readings not 'active', or nega­
tive); request for hospitalization and 
collection of additional 'spot' and 'over­
night' sputum specimens (for a positive 
bacteriological fmding on smear or on a 
single culture) ; request for putting a 
new case of tuberculosis on treatment 
(persons with two positive cultures). 
It may be noted that a case may well be 
diagnosed before al1 examinations are 
completed. In such a case the machine 
will print out a treatment card immediatey 
but await the results of othcr examinations 
(e.g., a third sputum specimen) before 
flllalising and punching the analysis card. 
n may be appreciated that with the 
procedures adopted, as described above, 
each investigation (X-ray reading, sputum 
examinations) was conducted independent­
ly and without reference to the results 
o[ other investigations. The results of 
the several investigations were collated 
in the (suitably programmed) computer 
and the classification of a case of tuber­
culosis was arrived at. Thus no bias was. 
introduced in performing the different 
investigations and the establishment of the 
case classification of an individual was 
completely objective. 
Filing of data - The updated name 
cards and the analysis cards are filed 
panehayat-wise. For each panchayat, 
at the end of five months by which time 
all results of examinations are expected 
to be a'{ailable, if cards for a few indivi­
duals had not yet been finalised these 
were inspected by the statistical staff, 
to determine why they had not been fInali­
zed by the machine and necessary action 
taken for fmalization. All cards were 
then checked by the machine for con­
sistency and missing entries, and correc­
tions made, as described earlier. If a 
person had been examined in a place other 
than the one where he was examined at 
intake a duplicate analysis card was made 
out with the individual number of the 
original panehayat and filed in the latter. 
The analysis cards were added to the main 
file (see below) already containing all 
previous analysis cards for each person, 
and tbe updated name cards were used for 
printing-out of individual cards for the 
next visit to the pancbayat. 
identification of new cases of tuber­
culosis - For every new bacillary case of 
tuberculosis, as classified by the compu­
ter, a manual check was made to ensure 
that the diagnosi.s was correct according to 
the original records from laboratory and 
X-ray readers. It was also ensured that 
finger prints obtained from the case at 
the time of collection of the sputum speci­
men which turned out to be positive were 
identical with those obtained at intake 
(vaccination). 
Data Jiles - Some data files of punched 
cards have been created for the purpose 
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of epidemiological analyscs and for the 
up-to-date census feed-back to the field. 
Four such important files are ; 
Main file ; All analysis cards arc HIed 
in individual order and for each individual 
kept in a chronological order. This is a 
mastcr file giving all information for cach 
person includcd in the trial. This file is 
continuously kept updated. However, 
total numbcr of cards in this file, at pre­
sent, is more than 2 mill lon, which is quite 
unwieldy for frequent handling. 
Intake lIlc ; A separate tile containing 
analysis cards of intake only is maintained. 
This gives all base-line information and 
call be used independently for analysis of 
intake data such as prevalences, without 
rcference to the main' IIIe. 
Case file The main file has 
been duplicated for all persons who 
are culture positive for M. tuberculosis 
on at least one specimen or have a 
positive smear in any round. This small 
file is very useful to keep count of all 
incidence cases and to carry out any analy­
sis on cases only. This file is kept conti­
nuously updated by adding cards of new 
cases as and when they are diagnosed. 
Name file : A file consisting of all 
name cards is maintained. When fresh 
census data is available the old name 
cards are replaced by new name cards 
with updated census. Normally the 
entire file is updated once in 2~ yr when 
a fresh census of the whole popnlation 
is taken. This file is used to print out 
population registers and to print out 
individual cards for resurveys and selec­
tive follow-up rounds. 
Population registers-After each survey 
(Le., once in 2~ yr), several population 
registers are printed by using the name 
and movement cards. One register, for 
every panchayat, is printed after sorting 
the cards according to household, thus 
showing all members of a family together; 
another register, also for each panchayat, 
is printed after sorting all names alphabe­
tically, including persons registered in a 
difTerent pancbayat but referred (through 
a movement card) to the particular 
panehayat; a third register (prepared after 
the intake only) is alphabetic in order, 
one for each panehayat union. Later if 
at the clinic, or at anyone or the peri­
pheral hcath institutions, a person 
attends for whom the individual number 
will not be available his identity in the 
study is established as follows; first his 
name is located in the alphabetic regis­
ter (which also gives household number, 
age and sex, and individual number) 
and then by referring to the correspond­
ing hous~hold register his identity con­
firmed through verifying the names of 
other	 members of his household. 
14.	 Incidence of infection and 
disease 
Incidence of infection - It may he re­
called that the entire study population, 
except children aged below one year, 
was eligible for testing with PPD-S and 
PPD-B at intake. In addition, repeat 
tuberculin tests with 3 IV of PPD-S were 
carried out in mutually exclusive random 
cluster samples of population at 2t mo 
(a 2 per cent sample), 2} yr (a 5 per 
cent sample), and 4 yr (an 85 per cent 
sample) after intake (see Chapters 5 and 
12). The population of the greater 
part of Trivellore town, constituting 
6 per cent of the study population, had 
all been included for retesting at 2t £110, 
and was therefore not included in the 
retestings at 21 and 4 yr from the results 
of which the incidence data given below 
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arc obtained. The repeat tests were carried 
out mainly to study the status of allergy 
after BeG vaccination and not for the 
purpose of direct estimation of the inci­
dence of infection. However, the informa­
tion as available is presented below. 
The results of 2! rno retesting would 
not provide data on incidence of infec­
tion as the duration after the first test 
was very short. It would be obvious that 
the incidence of infection as obtained 
from 2~ year and 4 yr retest results could 
be studied only among those who had been 
'vaccinated' with placebo. For this pur­
pose, decoding of the data was done 
on a computer by the ICMR headquarters 
in Delhi and the tabulations, in the 
form of summary tables, were obtained 
by the project. Thus the vaccination 
status of individual persons remained 
unknown to the project staff. 
Among the definite non-reactors 
(0-7 mrn to PPD-S) administered placebo 
at intake, in the age group 1-14 yr, 1,238 
and 19,397 children were included in the 
samples selected at 2t yr and 4 yr res­
pectively. Of these, 877 (71 per cent) 
and 13,216 (68 per cent) respectively 
were test-read. ]n age group 15 yr and 
above the test-read coverages were 49 per 
cent at 2tyr and 45 per cent at 4 yr. 
Criterion for defining a newly infected 
person - The methodology for defining 
a person as newly infected described by 
Raj Narain and associates7S has been 
adopted in this material. Briefly, the 
difference between the size of reaction at 
the second test and that at the first test 
for each individual is obtained and these 
differences are studied as distributions. 
Only persons in whom the sum of the two 
reactions was 20-59 ml11 were included in 
the 'distribution of differences' for reasons 
explained in the report referred to. 
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Fig. 9 shows the distri butions of 
differences of reactions as detailed above 
among children administered placebo at 
intake, separately for three age groups 
1-4, 5-9 and 10-14 yr. The distributions 
of dilTercncc~ between Teaetions at 2k 
yr and at intake and those between reac­
tions at 4 yr and at intake are respectively 
shown on the left half and right half of 
the figure. The distributions for other 
age groups were almost unimodal. 
It will be observed that among children 
aged 1-4 yr, the distribution aL the 2~ yr 
retest (Fig. 9, left half) is bimodal, the 
antimode being at ahout [2 mm. This 
would mean that in this age group, there 
are two dasses of individuals, one with 
an increase of 12 mm or more with the 
mode at 20 mill and anothcr with an 
increase of less than 12 nl1n with the 
mode at 4 111m. Individuals belonging to 
the former class are regarded as those 
with an evidence of new infection, and are 
defined as the 'newly infected'. It may 
however be observed that though the 
distributions of the uninfeeted and the 
newly infected arc not completely 
separate, the shapes of the two distribu­
tions being similar, the overlapping due 
to some 'not newly infected' being 
considered as 'newly infected' and viee­
versa would bc ncarly equal and thus in 
the estimation of newly infected, the 
errors mostly get cancelled. In the age 
group 5-9 yr, the bimodality is less 
obvious, even less so in the age group 
10-14 yr. In later age groups (not shown) 
it is hardly discernible. 
At 4 yr also (Fig. 9, right half), among 
children aged 1-4 yr at intake, the distri­
bution of dilTercnces in reactions to the 
two tests shows a similar phenomenon as 
at 21 yr except that tbe antimode is at 
10 mill. Again, in age groups 5-9 yr 
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Fig. 9 -- Distribution of differences bctween reactions to PPD-S at intake anu at 2!- years, or 
at intake and at 4 years, among children given placebo 
and above bimodality is not obviolls. 
Thus, in the following, estimates of the 
average annual incidence of infection arc 
derived using the criteria of an increase 
of 12 mrn or more for those retested at 
2t yr and an increase of 10 mm or more 
for those retested at 4 yr among persons 
reacting with 0-7 mm to PPD-S at intake. 
Estimates of annual incidence of 
injcct;oll-Table 22 presents the incidence 
of infection in age groups 1-4, 5-9, and 
10-14 yr among the placebo administered 
controls in the study population. At 
4 yr, the sample was very much larger 
and the observed estimates of the average 
annual incidence of infection were of the 
order of 3, 4 and 6 per cent for the age 
groups 1-4, 5-9 and 10-14 yr respectively. 
It is observed that the incidence rates 
increased with age at intake. Although, 
at 4 yr, the study population was Large, 
these estimates may not be considered as 
very precise, since in the population con­
cerned the test used was not sullleicntly 
specific, especially for the age goups 
5-9 and 10-14 yr. Nevertheless, infection 
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TABLE 22 - INCIDENCE OF INFECTION IN THE 
PLACEDO GROUP 
Age at intake (yr) 
1-4 5-9 10-14 
Interval, t yr 
No with 
0-7 mm 
a reaction 
at intake 
of 
297 363 217 
No with 
12 mm 
an increase 
or more 
of 
25 32 25 
Av. annual incidence of 
infection (%) 3.5 3.6 4.B 
Interval, 4 yr 
No with a reaction of 
0-7 mm at intake 451B 5467 3231 
No with an increase of 
10 mm or more 4B6 90B 690 
Av. annual incidence of 
infection (%) 2.B 4.4 5.8 
with M. tuberculosis in the trial area 
appears to have been at least as common as 
in other parts of India, if not more so. 
Raj Narain and associates78 described 
a method of calculating annual inddel1ce 
of infection from age specific prevalence 
of infection. Applying this indirect 
method to the prevalence data on infection 
as presented in Table 16, the annual inci­
deI1Ce of infection works out to 1.74 per 
ct:nt in age group 1-4 yr, 2.42 per cent in 
age group 5-9 yr and 4.03 per cent in 
age group 10-14 yr. Thcse rates are lower 
than those estimated by the direct method. 
Incidence of disease - As described 
earlier, the study population is followed 
up by resurveys systematically once in 
every 2t yr. Tn addition, selective 
casefinding is carried out at shorter inter­
vals and passive caseCtnding on a regular 
continuous basis (for details see Chapter 
12. 
All new cases diagnosed during the 
first 2t yr after intake by any of the 
above three approaches are referred to as 
incidence cases diagnosed during the 
'first follow-up'. 
An 'incidence bacillary cai>e' during the 
first follow-up is an individual who at 
intake was examined by X-ray and was 
either normal on X-ray or if abnormal 
was sputum negative and who became a 
baeillary case of tuben;ulosis during the 
first follow-up. Children ineligible for 
X-ray at intake (i.e., those aged below 
10 yr) and who became bacillary cases 
during the follow-up are also considered 
as incidence cases. 
The incidence of tuberculosis during 
first follow-up period was estimated by 
considering the new cases, as defmcd 
above, that arose from among the study 
population who completed all examina­
tions to which they were eligible, irres­
pective of BCG vaccination, and were 
abacillary at intake and examined during 
the follow-up. Thus children aged below 
one year who were not eligible for tuber­
culin testing would also be included. 
Sincc the report essentially has bearings 
on protection offered by BCG, data on 
incidence of disease is presented as related 
to tuberculin sensitivity, i.e., size of 
reaction to PPD-S at intake. Further, 
in the present report, the incidence data 
pertaining only to the first follow-up and 
only for culture positive cases (and not 
for culture negative smear positive or 
X-ray cases) is presented. Incidence data 
for all the first three follow-ups and for 
all catcgories of cases will be presented 
in subsequent reports. 
57 TUI3ERCULOSIS PREVENTION TRIAL, MADRAS 
Incidence of bacillary cases during first 
follow-up -- Table 24 presents the number 
of new bacillary cases, culture positive 
on at least two specimens, that occurred 
among the study population that was 
abacillary at intake. Thc cases are pre­
sented by age, sex, tuberculin sensitivity 
and X-ray results at intake, Table 24 
presents the corresponding numbers of 
new cascs culture positive on one specimen 
only. 
Of the 213,307 persons fo!lowed up 
133 [ new bacillary cases developed during 
the first follow-up. Of these, 908 were 
.culture positive on at least two specimens 
.and 423 positive on one specimen only. 
The overall incidence of pulmonary tuber­
.culosis confIrmed by culture during the 
first follow-up was 624 per 100,000 or 250 
per 100,000 per annum. Of the total 
1331 t:<lses, 985 occurred among males 
and 346 among females. The average 
annual incidence of disease among the 
107, 619 males was 366 per 100,000 and 
among the 105,688 females, 131 per 
100,000. Thus, the incidence of disease 
among males was nearly 3 times of that 
among females. The incidence of disease 
increased with age for both males and 
females. 
Of particular intercst in connection 
with the effect of BCG vaccination is the 
distribution of ne,v cases as related to 
the tuberculin reaction at intake. Out of 
the total 1331 culture positive cases 
diagnosed during the first follow-up 52, 
21, 85 and 1173 cascs occurred from 
among those who at intake reacted with 
0-7 mm, 8-11 mm, 12-15 mm and 16 mm 
or more respectively. Correspondingly, 
the annual incidence of disease (per 
100,000) during the first follow-up works 
out to 21, 55, 192 and 563 respectively. 
The incidence of disease was much lower 
among thosc not infected at intake as 
compared to that among infected (even 
when considering that two-thirds were 
vaccinated ; see Table 26). A similar 
'finding has also been reported from other 
surveys conducted in south India9':,2. 
15. The effect of BeG vaccination 
The primary objective of the study 
was to obtain a precise est.imate of the 
protective effect of BCG vat:cLnation in 
the non-infected, the main subsidiary 
objectives being to study the influences of 
dosage and strain on the protective effect. 
Thc design of the trial provided for the 
study of the protective cffect through 
comparison of the incidencc of disease 
among the vaccinated and among the 
controls. Further, the procedures adop­
ted provided for the study of the pro­
tective effect against the developmcnt of 
tuberculosis especially cases positive on 
culture. 
The rationale of BCG vaccination is 
to substitute the natural and potentially 
harmful primary infection with virulent 
tuberele bacilli hy an artificial and inno­
cuous primary infection with attenuated 
bacilli that have maintained the immuno­
genic properties but not the pathogeni­
city of the virulent bacilli. Among the im­
munogenic properties are the enhanced 
resistance to a subsequent cxposure to 
virulent infection, but also immune reac­
tions such as induction of delayed hyper­
sensitivity. 
Development of delayed hypersensi­
tivity to mycobacterial antigens leading 
to its demonstration as cutaneous sensi­
tivity to tuberculin has becn cxtensively 
used for monitoring the immediate effects 
of BCG vaccination. The level of tuber­
culin sensitivity induced by BCG vacei­
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TARLE 23 - NEw CASES Of TUDERCULOSIS, CULTURE POSITIVE ON AT LEAST Two S"FCIM~NS, DURING 
'fHI: f7msT FOLLOW-UP DY AGE, SEX, TunERCULlN REACTION AND X-RAY RESULT (fRRESf'E nVE OF 
BeG VACCINATION) AT INTAKC 
Number of new cases Number of new cas.:s 
X-ray result at intake X-ray result Ht intake 
Age at No No 
intake followed-up Ineligible Others followed-up Ineligible Others 
(yr) or normal or normal 
M F M F M F M F M F M 
0-7 mm to PPD-S 12-15111111 Lo PPD-S 
1-4 13651* 13410'" 3 1 110 105 
5-14 22929 21980 2 J770 1227 I -­
15-24 4455 5495 2 2155 1214 I 1 
25-34 1770 4579 I 3 2019 1673 4 2 2 
35-44 1121 2773 1 1547 1513 5 R 2 
45-54 837 1737 I 1276 Il2S 7 10 ] 
55-64 607 fin I 790 624 2 1 3 
65+ 350 280 I 397 188 I 5 1 
Total 45720 51126 10 7 3 3 10064 7672 19 4 27 7 
B-LJ mill to PPD-S 16-1- mm to 1'PD-S 
1-4 277 237 451 470 I 
5-14 2647 2098 5842 5045 5 5 2 
15-24 1560 1285 2 7389 5302 31 6 24 6 
25-34 916 1576 2 2 9589 9165 36 15 58 22 
35-44 6114 1280 3 8565 8527 51 12 ]00 40 
45-54 561 937 2 6835 6192 42 6 llll 32 
55-64 426 516 2 4086 3075 23 5 IH\ 18 
65+ 205 166 I 1802 1019 10 2 48 6 
Total 7276 8095 4 5 6 44559 38795 ]98 52 436 126 
*Children aged less than 1 yr who were ineligible for tuberculin testing are also included 
nation is an indication of the quality of 
the vaccination since this level is known 
to be correlated with thc dose of (live) 
vaccine actually introduced into the skin19• 
Moreover, delayed hypersensitivity, as it 
reflects cell-mediated immunity, may be 
related to the proteetion afforded79 • 
Thus, in the assessment of the effect 
of BCG vaccination in the prcsent study, 
the development and duration of delayed 
hypersensitivity induced by BCG has been 
studied in addition to the incidence of 
tuberculosis among the vaccinated and 
among the controls. 
--- ---
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TABLE 24 - NEW CASES OF TUB!:RCULOSIS, CULTURE POSITIVE ON ONE SPECIMEN ONLY, DURING THE 
FJRST FOLl.OW-UP IlY Am:, s~:x, TUD[RCULlN REACTION AND X-RAY RESULT (ltutESp[CrrYE OF BCG 
V."CCINATJON) AT 'INTAKE 
Number of new cases Number of new cases 
Age at No X-ray result at intake No X-ray result at intake 
intake followed-up followed-lip 
(yr) Ineligible Others Ineligible Others 
or normal or normal 
M F M F M M F M F M 
0-7 Tlllll to 1'1'O-S 12-15 mm to PPD-S 
1-4 1365[* 13410" 2 2 110 105 
5-14 22929 21980 6 3 1770 1227 
15-24 4455 5495 1 2155 1214 3 1 
25-34 1770 4579 I I 2019 1673 1 I 
35-44 1121 2773 1 2 1547 15J3 2 I 
45-54 1\37 1737 2 1276 1128 I 3 I 
55-64 607 872 I 790 624 1 3 1 
651- 350 280 2 397 188 3 2 2 
Total 45720 51126 14 5 6 4 10064 7672 9 3 9 7 
8-11 111m to I'1'O-S '6-:- IllI11 to PPD-S 
1-4 277 237 451 470 
5-14 2647 2098 5842 5045 4 1 I 
15-24 1560 1285 73R9 5302 11 6 II 5 
25-34 916 1576 9589 9165 19 13 24 14 
35--44 684 1180 8565 8527 11 6 37 16 
45-54 561 937 6835 6192 II 9 39 19 
55-64 426 516 4086 :i075 12 3 33 19 
65 f- 205 166 1802 1019 3 4 25 5 
Total 7276 8095 2 44559 38795 71 42 170 78 
"S.:e foot-note under Table 23. 
BeG induced tubel'm!in sens/I/vily -- negative (0-7 mm to PPD-S) at intake. 
Development of BeG induced tuberculin As described earlier, repeat tuberculin 
sensitivity was studied among all persons tests with 3 IV of PPD-S were carried 
irrespective of age or initial tuberculin out in random samples of the population 
sensitivi ty. However, in the following, at 2'~ mo, n and 4 yr after vaeci­
data is presented only for children aged nation. As already explained, there did 
0-14 yr who were (definitely) tuberculin not appear to be any significant differences 
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between the various batches of vaccines 
used. They have been therefore clubbed 
in presenting the development and dura­
tion of delayed hypersensitivity. 
The results or retesting are presented 
in Table 25 and graphically, as frequency 
polygons, in Figs 10, II and 12, showing 
the distributions of reactions for the O. I 111g 
dose of BCG, the 0.01 mg dose of BCG 
and the placebo respectively. The obser­
vations in the age groups 0-4, 5-9 and 
10-14 yr (at Lntake) for the two doses of 
the vaccines are compared with the 
placebo to illustrate the level of tuberculin 
sensitivity induced and its development 
with time. It should be noted that in 
this eva] uation any boosting of tuber­
culin sensitivity as a result of repeated 
testing80 was avoided by testing different 
sample populations on each occasion. 
Development of hypersensitivity among 
those vaccinated with the 0.1 mg 
dose of BCG appeared highly satisfactory 
showing unimodal, almost normal, dis­
tributions with mean reaction sizes of 
16-17 mm. But after 2t yr this pattern 
had changed considerably with the dis­
tributions showing a definite shift to the 
left, with mean reaction sizes of 9-12 
mm suggesting a loss of sensitivity from 
2i 1110 to 2~. yr. There was no 
further loss of sensitivity seen from 2, 
to 4 yr. However, the average level of 
sensitivity at 2t and 4 yr still remained 
considerably higher than that in the 
placebo group. Both from Table 25 and 
Fig. 10 it is apparent that the degree of 
waning in tuberculin sensitivity from 
2i mo to 2t yr varied with age being 
most pronounced in the youngest children. 
The significance of the phenomenon of 
waning in tuberculin sensitivity is not 
clear. 
The findings are similar for those 
TABLE 25 - MEAN SIZE OF POST-VACCrNAnON
 
REACTIONS AT EACH OF THE 3 RliTE1>TINGS AMONG
 
CHILDREN REACT G WITH 0-7 MM AT INTAKE
 
Retested at 
Age at 
intake 2! rna n yr 4 yr 
(yr) 
No. Mean No. Mean No. Mean 
0.1 mg BCG 
0-4· 500 16.1 334 9.1 5252 9.8 
5-9 503 16.7 350 10.3 5518 11.3 
10-14 344 17.4 227 12.1 3184 12.6 
o 14 1347 16.7 911 10.3 13954 11.0 
om rng BCG 
0-4· 469 12.8 328 6.5 5269 7.8 
5-9 526 12.2 338 7.9 5439 9.1 
10-14 366 13.7 199 9.0 3147 10.4 
0-14 1361 12.8 865 7.6 13855 8.9 
Placebo 
0-4· 512 4.2 347 5.0 5261 6.2 
5-9 586 5.2 363 6.3 5467 7.9 
10-14 401 7.6 217 7.7 3231 9.2 
0-14 1499 5.5 927 6.1 13959 7.6 
·Children less than 1 rna-old are excluded 
vaccinated with 0.01 mg dose of BCG also, 
though the mean size of indurations were 
smaller at all levels and even at 21 mo 
the distributions tended to be bimodal. 
The observati.on made in this study 
that tuberculin sensitivity apparently 
waned during the first few years after 
vaccination and then remained at the­
same level appears to be very dilTerent 
from the one made by Horwitz and Bunch­
Christensen54. They reported that BeG 
induced allergy as elicited (using 2 TV of 
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No
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Fig. 10 - Post-vaccination allergy after 3 inter­
vals of time among those with an initial size of 
reaction of 0-7mm (e--eo at 2t rno; -, at 
2t yr; - - - -, at 4 yr; (persons vaccinated with the 
strong dose). 
RT 23 with Twcen 80) at 2 mo after 
vaccination among school children aged 
7 yr was almost unchanged after 5 yr. 
There were no unvaccinated controls in 
their study. 
It should be noted that in the abovc 
presentation thc sample at 2~ mo 
included an area (the 8 blocks of Tri­
vellore town previously mentioned) which 
was not represen led in the samples at 
2~ yr and 4 yr. However, the con­
clusions drawn were in no way affected 
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Fig. 11 - Post-vaccination allergy after 3 inter­
vals of time among those with an initial size of 
reaction of 0-7mm (persons vaccinated with 
the weakdose) 
when the data was reanalysed (not pre­
sented) after exduding the results from 
this area at 2l mo. 
Incidence of tuberculosis among the 
vaccinated and the controls - In studying 
the elTect of BCG vaccination, in adJition 
to culture positive cases, non-bacillary 
X-ray cases were also considered. For 
this purpose all new culture-negative X-ray 
cases (i.e., C or D by two readers) that 
occurred among persons who, at intake, 
were tuberculin negative (0-7 mm to 
PPD-S) and whose chest photofluoro­
V 
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Fig. 12 -' Tuberculin reaction lIfter :> intervals 
of time among those with an initial size of reaction 
of 0-7 mm (pel'sons given the placebo) 
grams were interpreted as normal, or 
were ineligible for X-ray, arc being review­
ed, along with matched controls, indepen­
dently by two X-ray readers. For this, all 
available photof!uorograms (from intakc 
to the last available) of each persall were 
submitted to eaeh of the two readers for 
an independent review. The readers, on 
the basis of the review of photofluoro­
grams, classified new cases of tuber­
culosis. Only persons so classified by 
both readers were considered as X-ray 
cases for the purpose of studying the 
effect of BeG vaccination. The photo­
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fiuorograms of persons who were classified 
as 'tuberculosis' by one of the two readcrs 
only were submitted to a third reader and 
persons for whom the classification was 
confirmed by the third reader were also 
considered as X-ray cases, The results 
of the review art: at present available for 
2 panchayat unions, Out of 433 pcrsons, 
whosc photofluorograms were submitted 
for review, 55 wcre classified as new X-ray 
cases by at least two readers. The distri­
bution of these cases by 'vaccination' 
status is also presented. 
As already explained, the vaccinations 
were extended to all ages und to indivi­
duals with any degrec of acquired tuber­
culin sensitivity. Table 26 presents the 
numbers of nc\v cases detected during the 
first n yr of follow-up separately for 
the vaCcinated and the control groups and 
for four difrerent levels of tuberculin 
(PPD-S) sensitivity at intake. Only new 
cases arising from among those whose 
photofluorograms were interpretcd as 
normal or were ineligihle for X-ray at 
i.ntake arc included. The distribution of 
cases positive on at least two cultures, of 
eases positive on one culture only and of 
X-ray cases (based 011 review) are shown 
under (a), (b) and (c) respectively. Exact 
relative incidence figures are not yet 
available, but it may be taken tbat the 
denominators for the vaccine groups and 
the placebo group are the same. Thus 
it is clear at a glance that in any of the 
groups, BeG vaccination, over 7t yr, 
had had no effect in offering protection 
against the development of pulmonary 
tuberculosis. The very remote possibility 
of one strain being associatcd with a 
protective and the other with a harmful 
effect was examined. As no such diffe­
rence was ohservcd the results of both 
strains have been combined. 
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TADLE 26 - DISTRIBUTION OF NEW CASES DURING
 
THE FIRST 7t YR OF FOl..l.OW-Ul', ACCUl<llING TO
 
VACCINATlO, STATUS
 
Tuberculin ReG, mg 
reaction at 
intake 0.1 0.01 Placeho Total 
Cases with at least two positive cultures 
0-7 3i 37 28 102 
8-11 14 17 14 45 
12- 5 40 34 38 112 
16 or morc' 259 257 287 80J 
Cases wilh one positive c.:ulture only 
0-7 22 28 19 69 
8-11 4 3 5 12 
12-15 20 13 8 41 
16 or morc* 90 91 82 263 
X-ray case: according to review" 
0-7 19 18 55 
·only a part of this group was eligihle for 
follow-up at 2nd and 3rd resurveys. 
"follow-up period : 5 yr 
It is seen that in all groups the large 
majority of cases occurred among those 
already infected at intake. In this con­
nection it should be noted that in 2/3rds 
of the panehayats, persons with a reaction 
of 16 mm or more at intake were not eli­
gible for adive follow-up during later 
rounds. 
The new cases arising from among the 
definite non-reactors, i.e., those reacting 
with 0-7 mm at intake, have been further 
distributed according to the time of the 
first observation of a positive culture as 
shown in Table 27. It is seen that there 
is a tendency for the number of cases to 
be actually higher among the vaccinated 
during the first two periods (5 yr) of 
follow-up. This tendency fails to attain 
TADlE 27 - DISTRIIlUTlO:'-l OF New CAS~S AMONG
 
PERSONS REACTL'IG WITH 0-7 MM AT INTAKE, SEPA­

IlAn.LY fOR 2~ YR ROUNDS, ACCORDING TO VACCI­
NATIUN STATUS
 
BCG, mg 
Round 0.1 0.01 Placebo Total 
Persons wilh at least two posi tivc cultures 
T 
11 
III 
4 
D 
20 
9 
15 
13 
2 
8 
18 
15 
36 
51 
Totlll 37 37 28 102 
Persons with one positive cui lure only 
T 7 5 4 l6 
1[ 10 19 32 
III 5 4 12 21 
Tolal 22 28 19 69 
statistical significance (0.10 > P > 0.05) 
if one considers only cases with at least 
two positive cultures. However, it be­
comes statistically significant (P < 0.01) 
if all bacillary cases, incl uding cases posi­
tive on one culture only, are considered. 
The observation that this tendency appears 
to be more pronounced for the weak 
vaccine than for the strong vaccine is 
not statistically significant. The tendency 
for the number of cases to be higher 
among the vaccinated is not seen during 
the third period (5-7t yr) of follow-up. 
In fact, among cases with one positive 
culture only, two-thirds of whom were 
aged less than 15 yr at intake, this ten­
dency is reversed in that the number of 
cases is higher in the control group. 
However, this does not attain statistical 
significance. 
All the 171 new bacillary cases arising 
from among the definite non-reactors at 
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intake are also distributed by vaccination 
status separately for two age-groups, 
0-14 and 15+yr at intake as shown in 
Table 28. It should be noted that thc 
majority (72 per cent) of the cases occurring 
among thosc aged 15 yr or more were 
culture positive on at least two specimens 
whereas the majority (67 per cent) of cascs 
in the 0-14 yr age group wcre culture 
positive on one specimen only. The 
patlern of the distribution of cases seen 
in Table 28 remains almost thc same as 
in Table 27. 
Those reacting with 16 mill or more at 
intake have also been further distributed 
according to the time of the first obser­
vation o[ a positive culture as shown in 
Table 29. As already mentioned, the 
apparent decrease in the number of new 
cases with time is due to the fact that in 
2j3rds of the panchayats, persons with 
reactions measuring 16 mm or more at 
intake wcrc not eligible for active follow-up 
during later rounds. It is seen from 
Table 29 that the results are similar for 
all the three periods of [ollow-up and 
BCG vaccination did not seem to have 
any effect, either bcnclit:ial or harmful, 
on persons already infected at the time of 
vaecinati on. 
DjSCDssio 
This report presents the findings of a 
controllcd trial of the protective effect 
of BCG vaccination against pulmonary 
tuberculosis in a rural community in 
India during a 7~- yr follow-up of the 
study population. The report also docu­
ments the design and the procedures of 
the study in detail, and presents the 
essential epidemiological features of the 
study population. 
The study design, a form of factorial 
design, may be considered as superior to 
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TABLE 28 - DISTRIDUTION, ny AGE, OF THE 171 
NEW BACILLARY CASES AMONG PERSONS REACTING 
WITH 0-7 MM AT INTAKE, SEPARATELY FOR 2t YR 
ROUNDS, ACCORDING TO VACCINATION STATUS 
DCG, mg 
Round Age at 
intake 
(yr) 
0.1 0.01 Placebo Total 
I 0-14 
15+ 
7 
4 
7 
7 
4 
2 
18 
13 
Total 11 14 6 31 
0-14 10 II 4 25 
1I 15+ 13 23 7 43 
Total 23 34 11 68 
III 0-14 7 7 18 32 
15+ 18 10 12 40 
Total 25 17 30 72 
TABLE 29 - DISTRlDUTION OF NEW CASES AMONO 
PERSONS REACTING WITH 16 MM OR MORE AT 
INTAKE, SEPARATELY FOR 2! YR ROUNDS, ACCOR­
DING TO VACCINATION STATUS 
BCG, mg 
Round 0.1 0.01 Placebo Total 
Persons with at least two positive cultures 
I 65 68 78 211 
J[ 101 99 107 307 
m 93 90 102 285 
Total 259 257 287 803 
Persons with one positive culture only 
I 36 29 30 95 
II 24 33 28 85 
III 30 29 24 83 
Total 90 91 82 263 
------------- ----
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some other possible designs as every 
individual included in the study contri­
butes to each one of the comparisons 
under study. Further, the design also 
enables the study of interactions between 
the factors (here, the dose and the strain 
of BCG). 
The procedures adopted had the 
following main characteristics : the study 
was planned to obtain estimates of the 
protective effect of BCG vaccination 
especially against the development of 
pulmonary tuberculosis proved bacterio­
logically; the potency of vaccines used 
in the study were assessed through quality 
control tests, post vaccination allergy and 
also it was ensured that thcse vaccines 
would be available as seed-lots for any 
future use; the techniques adopted were 
standardised and the procedures of intake, 
[ollow-up and diagnosis of a case of 
tuberculosis ensured complete objectivity 
of each procedure; and finally, the follow­
up procedures were systematic and 
intensive in an effort to identify and 
document all new cases of pulmonary 
tuberculosis occurring in the study popu­
lation during follow-up. 
The study population wa.s characterised 
by high prevalences of tuberculous infec­
tion, nonspecific sensitivity and tuber­
culolls (pulmonary) disease as well as high 
incidences of tLlbereulous infection and 
disease. The prevalence of nonspecific 
sensitivity was so high that even with the 
very large study population adequate 
numbers of persons, without initial non­
specific sensitivity, among whom the 
effect of BeG vaccination could be studied 
separately, could not be obtained. 
The results of the trial reported here 
show that BCG did not confer any pro­
tection against the development of pul­
monary tuberculosis during the first 7t 
years after vaccination. Under the cit­
cumstances, the question of examining the 
significance of the differences in protective 
effect between vaccine strains or dosages 
does not arise. 
Details of 8 BCG trials, including 
the present one, in which the protection 
observed varied from none to 80 per cent 
are given in Table 30. BCG vaccination 
has been the subject of controversy 
throughout its more than 50 yr long 
history. With this ncw result at hand, 
that BCG did not protect (until now) in 
this trial, it is perhaps appropriate to 
discuss some of the hypotheses that may 
explain the difTerent findings. 
As mentioned earlier, the influence of 
nonspecific sensitivity and potency of 
vaccine used were offered as the main 
possible explanations for the considerable 
differences in the estimates of protective 
effect observed in the trials conducted 
earlier. As a result while planning the 
present study, care was taken not only to 
select two of the best strains of BCG in 
use but also to ensure that these strains 
would be available as seed-lots for any 
future nse. Also, right from the stage of 
planning of the study it was intended to 
carry out a similar study in another area 
in India where the prevalence of nOLl­
specific sensitivity was low or non-existent. 
Studies on the prevalence of mycobacterial 
sensitivity in various parts of the country 
revealed that only population in areas 
situated at high altitudes had lower pre­
valences of non-specifIc sensitivity though 
it was not completely absent. The popu­
lation in these areas however, are very 
small in relation to the total population 
of the country. Carrying out another 
BCG trial in such small and scattered 
population groups would operationally be 
very difficult and, even if such a study were 
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TAI3J.E 30 - PROTECTiON ODTAINED IN EIGHT CONTROLLED TRIALS OF BCG VACCINATION AGAlNSr 
TUJJfRCULOSIS 
Ref. Intake Duration of Percentage 
Trial and suhje(;[s no period observation protection 
(yr) 
N. American Indians: 
(1 to III yr age) 1 1935-311 9-11 gO 
Chicago ; infants 18 I937-48 12-23 75 
Georgia ; School children 
(6 to 17 yr age) 6 1947 20 Nil 
Puerlo Rico: general population 
(helow 20 yr age) 4 1949-51 5!-i:\ .11 
Georgia and Alabama : general population 
(age 5 yr and above) 5 1950 14 14 
Great Britain : school children 
(14 to 15~ yr age) 3 1950-52 15 7H 
Madanapalle, south India: general 
(all ages) population 114 1950-55 9-14 3() 
Chingleput, south India ; general Present 
(all ages) population trial 1968-71 71 Nil 
to be carried out and it was shown that 
BCG did protect in the absence of non­
specific sensitivity, the applicability of the 
findings would indeed be very much limited 
for the country as a whole. This is 
possibly true of many other, and especial­
ly, developing countries of the world. 
The above argument assumes that 
nonspecific sensitivity could have influ­
enced and masked the protective effect 
of BCG vaccination. This, however, 
may not havc bcen quite true as shown 
by the following. In their painstaking 
animal experiments, Palmer and LongU 
showed that in guineapigs, 'atypical' 
strains of mycobacteria conferred a lower 
protection than BCG : M. kansasii gave 
results close to those of BCG, while strains 
of the avian group (Runyon groups II 
and III) gave intermediate results, and 
rapid growers vcry little. Thc 'atypieals', 
isolatcd from the sputum specimens 
obtained from the present study popula­
tion, representing the environmental 
mycobacteria, in all probability causing 
the nonspecific sensitivity in the study 
population, comprised 1.5 per cent of 
photochromogens, 68 per cent of groups 
II and HI and 30.5 per cent of rapid 
growers. One would thcn expect that 
'atypical' sensitization would result in 
an apparent reduction of the effect of 
BCG but not abolish the effect altogether. 
This hypothesis however, could not have 
been tested in the study population, 
because of the very high prevalence of 
nonspecific sensitivity, even if some 
(say, 30 per cent) protection had been 
observed in the study. However, the 
hypothesis has once been tested, retros­
pectively, in thc study in Puerto Rico : 
vaccine and placebo had been allocated 
irrespective of the reaction to a high-dose 
test, and it turned out that there was thc 
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same low protection in those posItive 
and in those negative to the high-dose 
test3i '81. It is thus unlikely, though not 
impossible, that nonspecific sensitivity was 
the sole factor responsible for the complete 
lack of protective effect of BCG observed 
in the present trial. 
There is no doubt that BeG strains 
mutate in terms of colony morphology 
and in terms of antigenicity. For the 
Danish strain, the evidence available 
indicates that the strain used in this 
trial had not mutated from the strain 
used earlier in the British trial where a 
substantial protection was observed. 
Three circumstances favour the hypothesis 
that there was no genetic change in the 
strain between 1952 and 1960 (when the 
strain was made into a stable seed-lot). 
First, every year for the last 30 yr, the 
allergenicity of the Danish vaccine has 
been monitored in Danish school childrcn 
and there has been no change over this 
period. Second, the methods nsed to 
propagate this strain between 1947 and 
1960 were conservative, as advocated by 
Calmette. Third, a comparison of vacc­
ines prepared from the seed-lot with the 
vaccines prepared from cultures main­
tained by culture transfcrs from 1958 to 
1965, did not reveal any differences m 
morphology, antigenicity or virulence in 
animals, or in aHergcnicity in children. 
As regards the Frcnch strain, there was a 
mutation in pigmentation in the late 
19505, but the French \vorkers feel that 
they succeeded in saving the original 
strain by back-selection. In the animal 
expcriments conducted at the Inter­
national Referencc Centre for BCG, 
Copenhagen['li'57 several BCG strains 
including the French and Danish strains 
were studied for virulence for hamsters 
and for protective effect in bank voles. 
It was found that the residual virulence 
and the protective effect of the French 
strain were quitc satisfactory; in fact, 
in terms of survival of bank voles as a 
function of vaccine dose, the French strain 
was the strongest of all strains used in­
cluding the Danish strain. Also, in a 
recent experiment by D. W. Smith and 
co-workers (personal communication, 
1979), the French strain protected guinea­
pigs well, thongh significantly less than did 
the Danish strain. Thus, therc is much 
circumstantial evidence that the strains 
used in this trial were 'genuine' BeG. A 
meeting of chiefs of quality control 
laboratories, held in Copenhagen in 
February 1978, concluded that the vaccines 
used in this trial were of good quality. 
Thc methods and materials of the study 
were scrutinised at a meeting of experts 
held in Madras in October 1977, and it 
was eonduded that there were no apparent 
flaws in the procedures followed in the 
study. With the very involved code for 
vaccine ampoules conceivably a true 
protection might havc been masked 
by labelling or recording errors. How­
ever, since a blind reading of vaccination 
lesions in a very large proportion of the 
study popUlation tallied with the records 
of the codes in 99.8 per cent, such record­
ing errors cannot havc influenced the 
results. 
Vaccines prepared from the Danish 
strain were used in the British as well as 
in the present trial. In the study in 
British school-leavers during the first 
7~ yr of follow-up, the incidence of tuber­
culosis observed was higher among non­
reactors than that among reactors. On 
the other hand, in the present study during 
a similar period of foHow-up the incidence 
of bacillary disease among the non­
reactors (0-11 mm) at intake was much 
68 Indian J. Med. Res. 72 July (Suppl.) 1980 
lower than that among the reactors. 
This observation remains the same cven 
when persons in the age group 10 to 19 yr 
only, in the present study, whose age 
would be nearer to the age of the parti­
cipants in the British trial, are considered. 
However, in addition to the differences 
in the age of the participants, the two 
studies arc difTerent in several other 
aspects, for instance, tuberculins used 
and detinition of a case of tuberculosis, 
and are thus, not strictly comparable. 
Even so, the epidemiological situation in 
thc present study, appears to be quite 
different from what was observed among 
the school-leavers in Britain. In the study 
population of the 'longitudinal survey', in 
a rural population of south India conduc­
ted from 1960 onwards by the National 
Tuberculosis Institute, Bangalore52, the 
annual incidence of new bacillary cases, 
among those with an initial reaction of 
0-9 mm to RT 23 (1 TU, with Tween 80), 
was estimated at 58 per 100,000 while 
in the present study among those reacting 
with 0-7 mm to 3 IU of PPD-S and be­
longing to the same age group (5 yr and 
above), it was 25 per 100,000, or among 
those reacting with 0-11 mm at intake, 
31 per 100,000. Among the reactors, in 
the Bangalore study, thc annual incidence 
was 291 and in the prC5ent study, 503 per 
100,000. Although the data are not 
strictly comparable, incidence of tuber­
culosis among non-reactors to tuberculin 
in the present study, as weIl as in the 
Bangalore study appears to be very low 
in relation to that reported in the British 
trial and further, lower in the present 
study than in Bangalore district. The 
very much lower incidence among non­
rcactors and a considerably higber inci­
dence among reactors in the present study 
is a striking finding. It has also been 
shown that in the present study the 
incidence of infection is very high. Thus, 
we arc left with the impression that while 
incidence of infection is vcry high, those 
that are recently infected rarely progress 
to manifest disease. Incidence of tuber­
culosis is high but only among the middle 
aged and especially elderly men, indivi­
dua.ls who must have been first infected 
many years ago. 
The high incidence of infection, the 
vcry low incidence of disease among non­
reactors associated with a high incidence 
of disease among reactors suggest that a 
large proportion of cases occur not as a 
result of primary infection but as a result 
of cither endogenous reactivation or 
exogenous reinfection. If most of the­
cases do occur as a result of exogenous 
rcinfection the question arises whether 
BeG can protect at all against such disease 
and whether this has any bearing on the 
dilTerence observed in the protcctive effects. 
between the British and the prescnt lrials_ 
However, whether all or a large proportion 
of cases occurring among the initia.l 11on­
reactors in the present trial, during the 
first 7{ yr of follow-up, were also due to­
exogenous reinfection is difficult to deter­
mll1e. 
It could be argued that the lack of 
protection as well as the tendency for the 
number of cases to be higher among the 
vaccinated (as shown in Chapter 15) is 
due to the vaccinated individuals being 
at an increased risk of developing tuber­
culosis if they were infected within 3 wk 
after vaccination, i,e" before the mani­
festation of cell-mediated immunity. This 
however, is unlikely and not borne out 
by tbe fmdings : persons contracting 
infection within a period of 3 wk after 
vaccination and then progressing into 
bacillary cases would be extremely few 
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and even then one would expect the surplus 
cases to be confined to the first period of 
follow-up only and not beyond. One 
other posslbiJily that could be considered 
in this regard is that BCG itself might 
be the causatlve agent of lung tuberculosis, 
and that the positive cultures obtained in 
thcse cases were BeG cultures. However, 
this also is not borne out by the results: 
the results of niacin tests on the cultures 
of sputum specimens from aU these cases 
were strongly positive (2+) indicating 
that the organ isms were M. tuberculosis 
and not BCG, since niacin tests on BCG 
cultures of the Danish and French strains 
are either negative or weakly positive 
(trace reactions)8~. 
The tendency for the number of cases 
to be higher among the vaccinated was not 
seen during thc third period of follow-up. 
There was no difference in the number of 
new cases positive on at least two cultures 
dcveloping iu the vaccinated and the 
control groups. But, for cases positive 
on one culture only, majority of whom 
were in the 0-14 yr age group, a tendency 
was seen for the number of cases to be 
higher in the control group. Howevcr, 
it remains to be seen whether this tendency 
wiII be confirmed in the fourth period of 
follow-up. 
A local phenomenon that may be of 
relevance is the frequency of strains of 
A1. tuhaculosis that are of low-virulence 
in the guineapig. This phenomenon was 
exhaustively studied by Mitchison83, 
who found these low-virulence strains to 
bc susceptible to hydrogen peroxide, 
though they tended to be catalase-positive. 
Nothing seems to be known, however, 
about the epidemiological significance of 
these strains. They have been isolated 
from previously untreated patients 
admitted to the Tuberculosis Chemo­
therapy Centre, Madras, and they were 
niacin-positive and isoniazid sensitive. 
Evidence from elsewhere in India is scanty 
but compatible with the existence of these 
low-virulence strains in other parts of 
the country. Work is now underway 
in this project to study the distribution 
of such strains, especially in regard to 
age distribution, infection history, and 
fate of the patients. While there is as yet 
no indication of an association belween 
the prevalence of these strains and the 
BCG results, it nevertheless seems worth­
while to investigate this phenomenon. 
In conclusion, the present study has 
revcaled that BeG> over a 7~ yr 
did not show any protection against the 
devclopment of pulmonary tuberculosis. 
Also, though the incidence of pulmonary 
tuberculosis was high in the study popu­
lation, it was much less freqnent among 
initial non-reactors to tuberculin, the 
majority of whom werc in the younger age 
groups, and who could be expected to 
benefit frolll BCG vaccination. However, 
it should be pointed out tbat results of 
thc study may not be extrapolated to in­
fants, sinee infant tuberculosis was not 
observed in the trial. 
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